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Abstract 
The present research deals with the development of silk fibroin (SF) and chitosan (CS) based 
microporous 3D scaffolds for cartilage tissue engineering applications. Porous scaffolds 
prepared from SF/CS blends with varying ratio of SF and CS by freeze drying method were 
characterized for physicochemical, mechanical and biological properties. Among the 
various blend ratios, SF/CS with 80:20 blend was found to be the most favourable for 
achieving certain superior scaffold properties than other SF/CS blends. The scaffold 
possesses open pore microstructure with interconnected pore network with desired pore size 
(71-210 µm), average pore size (186±32.2 µm), porosity (82.2±1.3%) and compressive 
strength (190 ±0.2kPa). Bioactive molecules namely glucosamine sulphate (Glu) and 
chondroitin sulphate (Chs),the structural components of native cartilage tissue were added 
individually and in combination with the aim of improving cell supportive and 
glycosaminoglycan (GAG) secretive properties thereby facilitating cartilage specific ECM 
production. Thus, SF/CS/Glu and SF/CS/Chs scaffolds with varying percentage of Chs and 
Glu concentrations were developed. The SF/CS/Glu scaffold with 1% (w/v) Glu was the 
most favourable composition have pore size of 40-190 µm, average pore size of 104±19.6 
µm, 79.6+4.12% porosity and 202 ±12 kPa compressive strength. A marginal improvement 
in scaffold property was also achieved specifically by the addition of 0.8 % (w/v) Chs. The 
scaffold possess a pore size of 44-196 µm, average pore size 105±19.5% porosity of 
87+2.13% and 204 ±13 kPa compressive strength. In-vitro cell culture study using human 
mesenchymal stem cell (hMSCs) derived from umbilical cord blood (UCB) has shown an 
enhanced cell attachment, proliferation and differentiation (GAG assay) with SF/CS/Chs 
scaffolds than its counterpart SF/CS and SF/CS/Glu scaffolds. An enhanced scaffold 
porosity, hydrophilicity, cell adhesion and cell proliferation were further achieved by the 
incorporation both Glu and Chs in combination into SF/CS blend. Moreover, the increased 
GAG secretion shown by SF/CS/Glu/Chs scaffolds represents the superiority of the scaffold 
than the other scaffold towards cartilage tissue regeneration. Thus, it has been demonstrated 
ix 
that the scaffold comprising of SF/CS/Glu/Chs is the potential 3D polymer matrix which 
can be used as a suitable platform for cartilage tissue regeneration. 
Key words: Cartilage; tissue engineering; silk fibroin; chitosan; glucosamine sulphate; chondroitin 
sulphate. 
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1.1 Background and significance of study 
Cartilage tissue reconstruction has become an important area in modern medical 
healthcare system for functional and aesthetic surgery. Articular cartilage is predominantly 
avascular, aneural, and alymphatic tissue [1] which heals poorly with time. It is composed 
of sparsely distributed chondrocytes embedded within a dense extracellular matrix (ECM) 
with primarily type II collagen and proteoglycans [23]. Injuries to the cartilage tissue can 
occur through various mechanisms either through blunt trauma that breaks a piece of 
cartilage from the end of the bone or due to the constant wear and tear of cartilage tissue 
with aging. Current clinical methods to treat cartilage defects include arthroscopic 
debridement/lavage, osteochondral grafting, microfracture, osteochondral transplantation 
etc.[4,5]. These clinical methods have several limitations like lack of integration at the 
implantation site, limited mobility, and durability of the implants etc. [4,5]. Cartilage tissue 
can be regenerated by tissue engineering approach, which involves the combined use of 
scaffolds, cells and growth factors. In this technique, the scaffold with a desired set of 
material property is an essential component to provide a specific direction for the growth, 
proliferation and differentiation of cells to their desired lineages [6,7]. Specifically, 
scaffolds intended for cartilage regeneration require certain properties that offer adequate 
nutrient and waste transport, adhesion to the defect site, minimal invasive implantation or 
injection, biocompatibility and biodegradability [7]. A temporary three dimensional 
scaffold should mimic the physiological properties and perform the function of a cartilage 
extracellular matrix, enabling a microenvironment that can induce chondrocytes into a 
functional state under in-vitro conditions [8].  
 
Choosing the right material for cartilage scaffold is a very important aspect for the 
ultimate function of the cartilage scaffold. Fabrication of scaffold utilizing the natural 
components of the cartilage will pave the way for better cartilage tissue regeneration [9]. In 
this context, a variety of natural polymers has been explored for the fabrication of scaffold 
matrices with desired properties [11,12,13]. Silk Fibroin (SF) is an attractive fibrous protein 
and has many biomedical applications because of its permeability to oxygen and water 
vapor and robust mechanical strength [15]. However, SF offers slow degradation, brittleness 
and lack of hydrophilicity, which limits its use in tissue engineering [15]. Chitosan (CS), is 
biocompatible and biodegradable polymer have an excellent wound healing property [16]. 
Moreover, CS has its inherent GAG residues that can aid in cartilage tissue growth [15,16]. 
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However, its rapid degradation rate and low mechanical strength limits its application in 
tissue engineering [16]. Overall, the use of SF or CS alone is not suitable as scaffold 
material. In contrast, a few researchers have studied the effect of the combination of these 
two natural polymers and reported the resultant SF/CS blend with excellent scaffold 
properties [17,18,19]. However, in most of these studies, a specific ratio of SF/CS was used 
with the aim of exploring the suitability of the blend as scaffold material [17,19]. Therefore, 
a systematic study is essential to investigate the influence of SF/CS blend ratio on the 
properties of scaffold, targeting cartilage tissue regeneration.  
Glucosamine sulfate, present in the cartilage ECM acts as aprecursor for the synthesis 
of various molecules, including chondroitin sulfate, keratin sulfate etc [20]. It also preserves 
the structural integrity of the native cartilage [20]. Chondroitin sulfate, synthesized from 
glucosamine sulfate, predominantly has the water and nutrient absorption property, 
facilitates cell proliferation and also acts an anti-inflammatory agent [21,22,23]. Both Glu 
and Chs are used as oral supplements for regeneration of cartilage tissue due to their 
synergistic effect [24,25,26]. So, the use of these components can be beneficial in the 
fabrication of scaffolds to provide the necessary molecules for cell attachment and promote 
better regeneration of cartilage. 
The source of cells is another important factor in tissue engineering. Many studies have 
been reported on the culture of mesenchymal stem cells (MSCs) derived from the bone 
marrow of rats [27], adipose tissue [28,29] on SF/CS blend scaffolds for tissue regeneration. 
Umbilical cord blood (UCB), is a relatively cheaper source of stem cells [30,31]. The use 
of UCB involves limited ethical issues and has great potential in the field of stem cell 
engineering [32,33,34]. Thus, the use of MSCs, derived from UCB as a potential cell source 
for cartilage tissue regeneration using SF/CS blend scaffold is desirable. 
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1.2 Scaffolds as the foundation for tissue engineering 
Scaffolds are engineered three dimensioned structures which provide temporary sanctuaries 
to colonizing cells in order to develop a complete functional tissue [35]. After implantation 
into the body, they degrade with time, leaving behind the newly formed tissue mass that 
later develops into the target tissue. Therefore, preparation of the scaffold is a challenging 
task as the requirements are manifold [35,36]. High cell density combined with an 
interactive scaffold matrix are essential to enhace cell-scaffold interactions, important for 
tissue generation. 
1.3 Properties of ideal scaffolds 
Scaffolds have the critical task of facing a complex biological and sensitive system, the 
human body. Therefore, these scaffolds should be biocompatible, biodegradable, 
sufficiently porous, and contain sufficient compressive properties [37,38]. In addition to 
their material properties, the developed scaffold must be designed to accommodate the 
seeded cells and facilitate cellular interactions [39]. 
Ideally the scaffold should facilitate diffusion of nutrients, gases and waste products, 
provide complete and controlled degradation, support cytocompatibility, cell proliferation 
and differentiaition, create integration with the host tissue and act as temporary load bearing 
substrate until the new tissue is functional [40].  
The foremost requirement of any scaffold is its biocompatibility, which essentially 
means that the scaffold should be accepted by the living cells as a favorable guest and must 
not elicit any kind of immunological response and cytotoxicity [38,39,41]. The geometry 
and morphology of the scaffold play a pivot role in the support of cellular growth, 
proliferation and differentiation to a particular lineage [41]. Porosity is essential as it decides 
the proper supply of nourishment to cells, removal of waste products, supporting cell 
recruitment, cell aggregation, vascularisation and cell differentiation. Interconnectivity of 
pores facilitates cell migration and cell signaling [41]. The swelling properties of the 
scaffold is important as water permeability into the scaffold determines efficient nutrient 
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and waste material transport [42]. The biodegradation of the scaffold is a vital process as it 
permits new tissue ingrowth, remodeling of the extra-cellular matrix (ECM) and matches 
the formation of new tissue [42]. The mechanical strength of the scaffold ensures the 
stability of the scaffold in withstanding the compressive behavior in vivo [41,42]. 
Biofactor delivery is also an integral feature of a successful scaffold material [43], with 
equal support for scaffold degradation with time, and the formation of the regenerated tissue 
[43,44]. Scaffolds must also be sterilizable easily, to maintain aseptic conditions during 
implantation [41]. Thus, the choice of the biomaterial is vital [42].  
1.4 Scaffold fabrication techniques 
Scaffolds are prepared using a wide range of techniques like electrospinning, phase 
separation, solvent casting, rapid prototyping etc. The miscellany of fabrication methods is 
mainly because different tissues have different structural requirements in order to regenerate 
to their complete capacity. 
1.4.1 Electrospinning 
Nanoscale scaffold matrices are integral in exercising a deliberate control over better cell 
growth and proliferation. Even though the ECM is not completely reconstrucuted by these 
nanofibers, this method still makes engineering at the nanoscale level possible [45]. 
Scaffolds made with this technique have numerous advantages like extremely high surface-
to-volume ratio, controllable porosity, ability to produce nanofibers according to the size 
and shape required and also the ability to control the composition to obtain the desired 
functions [46]. A typical electrospinning system consists of a high voltage supply system, a 
tip (usually a syringe tip), a ground plate collector, which is either static (plate) or moving 
(rotating drum or mandrel). The principle of electrospinning is that when a polymer solution 
is introduced in a high voltage field, it is accelerated towards the collector maintained at the 
opposite polarity. As a result, nanofibers are produced which are deposited over the 
collector. Factors that control the property of the scaffolds include polymer concentration, 
solvent concentration, tip to target distance, voltage supplied, humidity, extrusion speed of 
the syringe etc [47].  
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1.4.2 Phase separation 
Phase separation may be defined as the separation of a polymer solution into its constitutive 
phases due to the intervention of an external factor, in order to reduce system free energy 
[48]. This external factor may be pressure, temperature, solvents and nature of polymer 
used. As a result of the separation, two phases are produced, namely the polymer lean phase 
and polymer rich phase. The residual solvent is removed by evaporation or sublimation. The 
polymer rich phase solidifies and leaves behind a network of pores [48,49]. Polymer foams 
produced by phase separation can be tailor-made to meet specific needs by accordingly 
altering various process parameters. The various steps in phase separation process includes 
polymer dissolution, phase separation and gelation, solvent extraction from gel, freezing, 
freeze drying [49,50]. Process parameters that determine the characteristics of phase 
separated scaffolds are the solvent used, type of polymer used, polymer concentration, 
solvent exchange, thermal treatment and the order of procedures followed. Each process 
parameter has its own influence on the prepared porous scaffold [49,51]. 
The freeze drying technique, an offspring of the phase separation technique, is widely 
used to produce microporous scaffolds for numerous tissue engineering applications. 
Various types of porous materials like aligned, hybrid etc can be prepared by this method 
[51]. A typical freeze drying procedure includes the freezing of a solution followed by 
sublimation via freeze drying. The spaces occupied by the ice crystals are formed as pores, 
whose size can be altered by varying the freezing temperature and rate of freezing. For a 
larger pore size, extension of freezing time is necessary and vice versa for smaller pore sizes 
[51,52].  
The process of freeze drying may be divided into three steps namely freezing, primary 
drying and secondary drying [52]. In the first step, the desired solution is frozen to a solid 
state. This freezing can be achieved in a deep freezer, with liquid nitrogen or under 
controlled freezing conditions. Since the rate of freezing has a direct effect on the rate of 
sublimation and the size of pores formed, freezing is considered to be one of the most 
important steps in lyophilisation [53]. In primary drying, the frozen solution is subjected to 
low temperature and vacuum atmosphere which begins the sublimation procedure. 
Secondary drying process deals with desorbing any unreacted or unbound solvent 
molecules. At the end of this step, completely dried materials can be obtained [53].  
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Figure 1.1: Schematic representation of freeze drying procedure 
 
1.4.3 Particulate leaching 
Particulate leaching is employed to prepare scaffolds with controlled porosity. Porogens are 
added to the polymeric solution with a suitable solvent. After the evaporation of the solvent, 
the porogens are leached out in order to create highly porous matrices [54]. Depending upon 
the size and morphology of the porogen, the pores are produced and organize themselves 
accordingly. Most commonly used porogen particulates include salt, sucrose, ammonium 
chloride, paraffin beads, glass beads, ice particles etc. By having control over the amount, 
size and shape of porogen, the pore size can be altered.  It is a simple, easy technique that 
helps to control the pore geometry [55]. Choice of porogen size can be decided by sieving 
the particle to the required dimension. However, pore interconnectivity is not achieved with 
this process [55].  
1.4.4 Rapid prototyping 
Rapid prototyping, also known as solid free form technique enables the production of porous 
scaffolds by layer-layer manufacturing method. Scaffold models, such as images of bone 
defects, designed with the help of computer aided design (CAD) software [56] are expressed 
as cross sections. Ink jet printing technology with x and y axis technology is used to expel 
a binder from the jet head. The head moves according to the CAD data that has been entered 
into the computer, on top of a polymer powder surface. The binder dissolves and mingles 
with the neighbouring particles. The chamber of the piston is lowered in the z-axis and again 
refilled with an additional layer of powder and the entire procedure is continued. The 
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unbound material needs to be cleared after the final product has been completed [57].  The 
various other branches of rapid prototyping include 3D printing, stereolithography, selective 
laser sintering, fused deposition modeling, etc. Scaffolds with controlled porosity and high 
interconnectivity can be designed with the help of this technique. As a result, optimum 
mechanical and biological kinetics can be achieved [57]. 
1.5 Applications of scaffolds in cartilage tissue engineering 
The porous scaffolds prepared from various biomaterials, using varied techniques have 
profound applications in tissue engineering. Various tissues in the human body namely 
bone, cartilage, skin, liver, cornea, urinary bladder etc. can be repaired/regenerated by 
utilizing the scaffold architecture [58]. Soft tissues, in particular cartilage, demand more 
attention as they are located in regions which are prone to constant exposure to forces and 
trauma. Cartilage, a predominantly avascular, aneural, and alymphatic tissue, is composed 
of sparsely distributed chondrocytes embedded within a dense extracellular matrix (ECM) 
[58,59]. As this tissue has limited possibilities of self-repair, it is considered to be an ideal 
candidate for tissue engineering applications [60]. Current treatment methods utilized to 
treat cartilage defects include arthroscopic debridement / lavage, osteochondral grafting, 
microfracture, osteochondral transplantation etc [61,62]. There is a persistent need to 
improvise these methods mainly due to the lack of sufficient compatibility and 
biomechanical functions. Tissue engineering based methods like combinations of 
chondrocytes and copolymer scaffolds and grafts that contain gelatin [63], chondroitin [64], 
hyaluronan [64], human fibrin [65] and PGA [66] are being used to replace the defect tissue. 
In another report, genetic modification was done by introducing TGF-β1 gene into chitosan 
polymeric scaffolds to regenerate cartilage tissue [45]. 
1.6 Biomaterials for cartilage tissue scaffold 
Biomaterials for scaffolding applications have a wide range of sources starting from natural 
and synthetic origin polymers, bioactive ceramics and hydrogels [57]. Natural origin 
polymers are an immediate choice for scaffolds as they are composed of structural materials 
of tissues. They are advantageous in terms of their biocompatibility but may sometimes 
cause significant immune responses. Natural polymers that are currently in use as 
biopolymers for scaffolding applications include alginate, agarose, collagen, cellulose, 
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chitosan, gelatin, heparin, hyaluronic acid, elastin, fibrin, silk etc. [65]. Synthetic 
biomaterials are easily available with varied physical and mechanical properties [65,66]. 
Synthetic polymers like polyanhydrides, PLA, PLLA, PLGA, PCL and PVA are employed 
for scaffold manufacture [65,66]. Composites of these natural and synthetic polymers are 
also exploited to prepare scaffolds for a wide range of tissue regeneration purposes. 
Biocomposites based on silk have also been developed including silk-HA, silk-chitosan, 
silk-gelatin and silk- poly (butylene succinate) [66].  
The hybridization of both synthetic and natural polymers is done to evolve novel 
composite materials, both for physicochemical and biological benefits. Composites are 
prepared to utilize the properties of two or more constituents to provide a combined 
beneficial effect over the material and biological properties of the scaffold material. By 
combining various materials, it becomes easier to minimize undesirable effects and obtain 
materials of required features for specific applications [66]. Composite materials are chosen 
mainly based on the compatible blend of the composite materials [67]. The properties of the 
materials must correlate in a proper fashion so as to be in synchronization. Composites of 
polymers and ceramics improve mechanical property and tissue interaction. 
i. Silk 
Silk stands top on the list of advanced biomaterials used in tissue engineering owing 
to the reasons that it has excellent biocompatibility with robust mechanical strength 
[68]. It is a fibrillar protein which has the ability to be developed into a variety of 
forms including thin films [68], porous scaffolds [69], sponges [70] and hydrogels 
[70,71]. Silk possesses a molecular weight of about 370000 Da, a chain length of 
150 nm and a chain diameter of 0.45 nm [71]. The two main protein constituents of 
silk include silk fibroin and sericin [72]. The fibroin and sericin percentage is about 
60 and 40% in weight. Silk fibroin is a novel biomaterial which is biocompatible, 
biodegradable, non-immunogenic and mechanically strong [73]. 
Natural silk fibers have the ability to dissolve in limited solvents due to the presence 
of a large number of inter and intra-molecular hydrogen bond in fibroin and its high 
crystallinity [74]. Fibroin is insoluble in water and a few organic solvents, and 
instead, swells by 30-40%. Fibroin dissolves in concentrated aqueous, organic and  
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aqueous-organic salt solutions, namely LiBr, CaCl2,Ca(CNS)2, ZnCl2, NH4CNS, 
CuSO4 + NH4OH and Ca(NO3)2 [74]. 
ii. Chitosan 
Chitosan (CS) is a polysaccharide found as chitin in the shells of crustaceans. It 
contains β→1-4 glucosidic linkages. CS is considered to be an excellent biomaterial 
with properties like wound healing, anti-microbial activity, biocompatibility and less 
immunogenicity [75]. It can be prepared as scaffolds in order to provide growth 
factors and improve chondrocyte proliferation [76]. Being positively charged in 
acidic medium, CS can attract the negatively charges present in the plasma thus 
accelerating the wound healing process [77]. CS can be processed to prepare 
different forms of scaffolds namely hydrogels, thin films, porous scaffolds and 
nanofibers [78]. However, CS has certain limitations like lack of mechanical 
properties and rapid degradation which hampers its utilization as a prospective 
scaffold material [79]. 
iii. Glucosamine Sulfate 
Glucosamine sulfate is one of the major structural components of cartilage tissue, 
along with chondrocytes and hyaluronic acid [20]. The primary role of this 
component is to provide a structural framework to the chondrocyte network, along 
with sufficient nutrient balance. As a part of the proteoglycan structure, collaborated 
with collagen and noncollagenous glycoproteins [24], it provides the cartilage the 
ability to withstand compressive stress under various circumstances [24]. It also acts 
as the precursor molecule for the synthesis of various GAG protein including 
chondroitin sulfate, dermatan sulfate, keratin sulfate etc [20]. 
iv. Chondroitin Sulfate 
Chondroitin sulfate is a predominant component of the natural ECM of cartilage 
which is synthesized from glucosamine sulfate [21,63,80]. It plays an important part 
in maintaining the water and nutrient balance of the cartilage tissue. It possess anti 
inflammatory properties and is found to reduce pain [81]. It also has numerous cell 
supportive domains that influences clustering of cells promoting cell adhesion. It is 
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also involved in the signaling of various growth factors and chemokines like 
fibroblast derived growth factors [82].  
v. Collagen 
Collagen is natural biopolymer found in cartilage which induces the cell-binding 
motifs [83]. It has versatile properties like being readily modifiable into desired 
shapes without disturbing the basic structure, synergy with other biomolecules and 
promotes blood coagulation [84]. But, it has certain disadvantages like weak 
mechanical and thermal stability [83,84]. 
vi. Polylactic acid 
Polylactic acid (PLA) is an aliphatic polyester which can be degraded under 
physiological conditions [85,86]. It has high thermal stability and a low glass 
transition temperature [87]. It can form compatible blends with numerous other 
polymers. It finds extensive utilization in the field of controlled drug delivery 
[86,87].  
 
vii. Composites for cartilage tissue regeneration 
A number of researchers have worked on the composites of collagen and chondroitin 
sulfate as a biopolymer. The scaffolds are prepared by the co-precipitation of 
collagen and chondroitin sulfate or by attaching chondroitin molecules to collagen 
by a covalent link [88]. Since, there are studies which suggest the relation between 
chondroitin sulfate and chondrocyte culture, the dual influence of collagen and 
chondroitin sulfate produces significant results for the culture of chondrocytes. 
Moreover, while collagen increases the tensile strength of the scaffold, chondroitin 
sulfate improves cellular growth [88].  
Silk fibroin and chitosan are one of the most widely used polymer blends for 
numerous tissue regeneration applications. Silk fibroin has sufficient mechanical 
stability combined with biocompatibility which can be exploited as a favorable 
biomaterial. But, it suffers from drawbacks like less hydrophilicity and delayed 
degradation [15]. Chitosan contains cell adhesion sites which can enhance the 
wound healing process. It also possess antimicrobial properties. But, due to its rapid 
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degradation and lack of sufficient mechanical properties, the utilization of chitosan 
in tissue engineering applications is limited [16]. However, blends of silk fibroin 
and chitosan have been used to obtain scaffolds with optimum mechanical, 
biodegradation and cell supportive properties. Also, the culture of chondrocytes on 
the silk chitosan blend scaffolds has been found to enhance cartilage tissue 
regeneration [19].  
1.7 Stem cells for tissue engineering 
Stem cells are an important component of the tissue engineering process. They adhere 
to the surface of the biomaterial, grow, proliferate and differentiate into particular lineages 
[29]. Mesenchymal stem cells (MSCs) are widely used in numerous tissue engineering 
applications. The important sources of mesenchymal stem cells include bone marrow, 
placenta, umbilical cord blood, adipose tissue etc. They have a great potential in the area of 
tissue regeneration [32]. 
i. Adult stem cells 
Adult stem cells are undifferentiated group of cells found amongst the differentiated 
cells in tissues and organs [29]. They are usually found in muscle, bone marrow, skin, fat 
etc. These cells play a crucial role in repairing the native host tissue. Since they possess 
immunosuppressive ability, they can be used in allogenic transplants [33].  
ii. Embryonic stem cells  
These cells are found to originate from the blastocyst. They have the unique ability to 
differentiate into various somatic cells [34]. They possess self renewal capacity and can 
differentiate through precursor cells. They can differentiate into many cell types like 
chondrocytes, adipocytes, osteocytes etc [33]. But the usage of embryonic stem cells is 
limited due to ethical constraints.  
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iii. Mesenchymal stem cells (MSCs) 
MSCs, also called as somatic cells, are undifferentiated cells which are prominent in 
many organs and tissues. They have originated from the mesoderm and have the ability to 
develop in numerous tissues like cartilage, bone, blood etc [34]. They can self renew with 
time and can also be readily isolated, cultured under in-vitro conditions. They possess 
certain similarities to fibroblasts and are readily utilized in the field of tissue engineering 
for numerous applications [32]. 
1.8 Organization of thesis 
The whole thesis work has been arranged in the following chapters. 
Chapter 1 describes the structure of cartilage tissue and the need for its regeneration, 
tissue engineering and the various strategies in regenerating cartilage tissue. This chapter 
focuses on different scaffold fabrication techniques along with various natural, artificial and 
composite polymers which can be utilized as scaffold materials for cartilage tissue 
engineering. 
Chapter 2 presents the literature review on silk fibroin based polymer blend and 
composite scaffolds used for cartilage tissue engineering. Silk-chitosan based porous 
scaffolds with various blend ratios which have been developed till now have been briefly 
described.  
Chapter 3 defines scope and objective of the study.  
Chapter 4 describes the materials and detailed methodology adopted throughout the 
research work. The preparation of SF/CS based blend scaffolds and hybrid scaffolds and 
the various characterization techniques have been discussed in detail.  
Chapter 5 describes the results and discussion consisting of 4 parts that includes  
5 A: Development and characterization of SF/CS scaffolds.  
The first part of the research work describes the optimization of various blend ratios of 
SF and CS for the preparation of SF/CS porous scaffolds, followed by the various 
physicochemical, mechanical and biological characterizations.  
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5 B: Development and characterization of SF/CS/Glu scaffolds.  
The second part of the research work focuses on the improvement of cell affinity 
properties of SF/CS scaffolds by the addition of Glu. This part explains the preparation and 
characterization of SF/CS/Glu scaffolds to understand its role in cartilage tissue 
regeneration. 
5 C: Development and characterization of SF/CS/Chs scaffolds.  
The third part of the research work explains the addition of Chs to SF/CS scaffolds to 
validate its efficiency in improving numerous scaffold properties of SF/CS. The SF/CS/Chs 
scaffold preparation and characterization is described in this part. 
5 D: Effect of addition of Glu and Chs in combination on the scaffold property.  
The last part of the research work evaluates the effect of addition of Glu and Chs in 
combination towards the various SF/CS scaffold properties. This part also emphasizes the 
superior properties of SF/CS/Glu/Chs which can be utilized for cartilage tissue regeneration. 
Chapter 6 presents a brief summary of the research work highlighting the superior in-
vitro biocompatibility properties of the SF/CS based porous scaffolds which shows the 
potentiality of the developed scaffolds for potential cartilage tissue regeneration 
applications.  
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Cartilage repair has become important in modern medicine for both functional and esthetic 
surgery. The need for treatments options is strongly associated with the fact that native cartilage 
is a hypocellular, avascular and not innervated tissue and thus heals poorly [89]. Defects which 
are confined to the articular cartilage region require restoring the structural and functional 
wellbeing of the tissues as it has lost its inherent capacity to regenerate. Articular cartilage 
forms one of the most native tissues of the human body [89,90]. Cartilage has sparsely 
distributed chondrocytes embedded in a dense extracellular matrix (ECM) [82]. This ECM 
comprises of primarily type II collagen along with proteoglycans that supply the cartilage 
tissue with sufficient mechanical strength for proper function [2]. As cartilage possess a 
limited ability to self-repair, it is considered to be an ideal application for tissue engineering. 
Articular cartilage, a soft tissue by nature, requires materials that can be flexible, while not 
necessarily providing vascularization. The material must also cater to the optimal 
functionality of the tissue [4]. Current treatment options like tissue grafting, mosaic plasty, 
autologous chondrocyte transplantation may be temporarily palliative but do not encourage 
long term cure [5]. A promising alternative to this treatment methods is tissue engineering 
which allows the regeneration of any functional tissue by employing artificial matrices 
(scaffolds), cells and several growth factors. Novel features are being introduced into this 
technique in order to achieve better cell-material and cell-cell interactions [4]. 
Cartilage is primarily located on the outer surface of load bearing tissues and enables 
smooth movement of the joints. Molecules are transported in and out of the cartilage matrix 
with water which helps in providing lubrication and prevents friction.  Articular cartilage is 
a special type of hyaline cartilage which helps reduce the friction produced in the joints [5]. 
It is derived from the blastula stage of mesenchyme when the cells begin to secrete an 
extracellular cartilage matrix and form chondroblasts. These chondroblasts later come 
together and arrange in the dense matrix thus forming chondrocytes. Water is the major 
structural component and is responsible for load dependant deformation of the cartilage 
structure. Collagen, mainly present as collagen II offers the framework and tensile strength. 
Proteoglycans like chondroitin sulphate and dermatan sulphate provides electrostatic 
balance to the cartilage system [8]. Table 2.1 explains the basic structural components of 
cartilage tissue. 
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Table 2.1: Structural components of cartilage tissue 
Component of cartilage Proportion (%) 
Chondrocytes 1-10 
ECM 95 
Water 60-85 
Collagen 60 
Proteoglycans 25-35 
Glycoproteins 15-25 
 
 
Materials like fibrin, collagen, alginate, chitosan, hyaluronan etc belong to the natural 
origin polymers that were utilized for preparing scaffolds for cartilage tissue engineering. 
Fibrin glue is the end product from the clot reaction which is known to enhance the growth 
and proliferation of chondrocytes [91]. Peretti et al. developed a fibrin based scaffold mixed 
with lyophilized cartilage extract which was used to culture chondrocytes.This scaffold 
showed enhanced biomechanical properties in addition to implant preservation [91]. 
Collagen is a natural component of the osteochondral framework. It therefore, has the 
inherent property of promoting cell attachment and proliferation in the joint areas. 
Hydrogels made from collagen have been utilized for the in vitro growth study of bone 
marrow derived mesenchymal stem cells [88]. CS is a natural polysaccharide derived from 
the crustacean shells which has glycosminoglycan chains as a part of its structure. It can be 
prepared as scaffolds to supply growth factors and promote chondrocyte proliferation at the 
site of implantation [79]. Hydrogels act as injectable scaffolds as they can take up the shape 
of the defect in a minimal non invasive procedure. Their biomechanical properties are 
limited to the crosslinking density. Polyethyleneglycol hydrogels, after crosslinking and 
addition of specific peptide sequences support chondrogenesis [67]. CS can be prepared as 
scaffolds to supply growth factors and promote chondrocyte proliferation at the site of 
implantation [78]. Hydrogels act as injectable scaffolds as they can take up the shape of the 
defect in a minimal non invasive procedure. Their biomechanical properties are limited to 
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the crosslinking density [11]. Polyethyleneglycol hydrogels, after crosslinking and addition 
of specific peptide sequences support chondrogenesis [11]. 
Porous scaffolds, also known as sponges provide the desired porosity and surface area 
for cell adhesion and cell infiltration in the scaffolds. Also, the porous network is significant 
in providing efficient nutrient and gas exchange [68]. Nanofibrous networks also commonly 
called as meshes provide greater surface area and directionality for enhanced cell growth. 
The fiber diameter and interspace between fibers have a crucial impact over the cell 
behavior [47]. 
Wang et al investigated the effects of using silk scaffolds for potential cartilage tissue 
engineering applications. The chondrocytes proliferated slowly during the first 7 days of 
culture, with increase in the rate of cell proliferation over the next ten days. Most cell 
attachment was limited to the surface of scaffolds [94]. Uniform morphology and porosity 
was observed in freeze-dried sericin/gelatin blended scaffolds, with homogeneous pore size 
distributions. Enhanced mechanical properties were observed with increase in gelatin 
concentration. Presence of gelatin in addition to sericin also increased the number of pores 
and interconnectivity. Water swelling was also found to be uniform and retention was found 
to be up to several hours [94].  
Effect of SF / hyaluronic acid blend scaffolds on the growth and proliferation of MSC’s 
was investigated by Marcos et al. Increased swelling was observed in the blend scaffolds 
which may enable the infiltration of cells into the scaffolds. The enhanced cell arrangement 
can be attributed to a more organized pore morphology and material hydrophilicity. This, 
in turn, has favoured better cell attachment and proliferation [95]. Mandal et al reported the 
use of silk scaffolds for cell migration. Scaffolds were prepared by freezing silk solution for 
24 hours, sealed on all three sides except bottom with thermocole box, for uniform 
cooling.The insulation cover permits controlled cooling vapours from bottom. Notable 
changes with regard to pore size and porosity were evident in various freezing temperatures. 
Pores of diameter 200–250 µm were formed due to slow cooling at -20°C and -80°C. These 
scaffolds had limited porosity and pore interconnectivity. But scaffolds developed by rapid 
freezing at -196°C were found to possess 96% porosity [95].  
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Nazarov et al investigated the preparation of silk fibroin porous scaffolds by different 
techniques. The morphology of the scaffolds varied according to the concentration of the 
solution and alcohol used. High alcohol concentrations caused the scaffolds to become 
brittle. Pore size reduced with increase in concentration of the silk solution. Higher freezing 
temperatures above the glass transition temperature causes longer time for ice formation. 
The ice particles have a direct influence in pore size namely; greater freezing time causes 
larger ice crystal sizes and therefore larger pore size [68]. A novel method for the 
preparation of silk porous membranes was studied by Nogueira et al. Foaming was induced 
in the silk fibroin solution by mechanical agitation. The foam was collected and compressed 
between polystyrene plates by applying pressure to remove excessive water. The 
membranes, after ethanol treatment, were stable, but became brittle at room temperature. 
The scaffolds had an irregular pore arrangement, with only limited visible pores. The 
porosity and moisture content of the scaffold were 68% and 91%, respectively. Membranes 
produced using this method can be considered for large scale production, use of scaffold 
materials in tissue engineering applications [97]. 
Silk scaffolds with the desired porous structure were prepared by varying the silk in 
methanol [98]. The increase in fibroin concentration, decreases the pore size and increases 
the pore density. The water molecules were restricted in their movement during freezing 
due to fibroin molecules and as a result, smaller ice crystals were formed at higher fibroin 
concentration. The compressive strength along with the compressive modulus were 
increased with increase in fibroin concentration. The mechanical properties also enhanced 
due to the increased pore wall thickness which resulted from the decreased pore size. The 
addition of methanol makes the fibroin molecular chains better interactand rearrange to 
produce a crystalline structure, which would result in structures with different 
morphologies. Also, scaffold morphology could be affected by freezing temperature after 
methanol treatment. With increase in cooling rate, aggregate formation was favoured. 
Therefore, the small ice crystals are formed in the spaces once occupied by water, 
subsequently leading to formation of smaller pores. [98]. Feng et al reported the preparation 
of silk fibroin porous scaffolds using the freeze drying / foaming technique. The foam was 
collected by mechanical agitation of the SF solution and was compressed between glass 
plates to remove water present. They were then allowed to partly thaw at room temperature 
before freeze drying. The scaffolds showed both open and closed pore structures. The 
Chapter 2 Literature Review  
20 
porosity increased with the decrease of fibroin solution concentration. No flake like 
morphology was evident. The use of foaming and freeze drying technique leads to enhanced 
mechanical properties of the scaffolds [99]. The effect of the freezing method on the 
properties of lyophilized SF porous membranes was studied by Weska et al. In order to 
study the effect of varying freezing methods prior to lyophilization, porous SF membranes 
were shock frozen in liquid nitrogen (–196 °C) or slow frozen using an ultrafreezer at –80 
°C, for 24 hours. The main difference observed between the frozen and liquid nitrogen 
treated scaffolds was in the presence of water. Water was present in the samples before the 
freeze-drying procedure, and was the reason behind plastification of wet membranes. The 
quench freezing with liquid nitrogen and lyophilization caused the collapse of the 
membranes. On the other hand, slow cooling preserved membrane integrity. The 
denaturation of proteins increases under conditions when the freezing creates a large ice 
surface area. The observed results indicate that the freezing rate is an essential parameter 
that decides the integrity of lyophilized porous SF membranes [97]. 
Nam et al studied the effect of freezing temperature, alcohol addition and molecular 
weight to the morphology of regenerated SF membranes. SF porous membranes were 
prepared by varying freezing temperatures and solvents, followed by lyophilisation. 
Different freezing temperatures as such did not affect the morphology of the SF membrane. 
But the addition of methanol promoted aggregate particle formation which caused the 
random coil to change into a β-sheet conformation. At a lower cooling rate, protein 
aggregate formation takes place in a speed slow sufficient to synthesize an aggregate with 
larger voids which had been occupied by water. So, the formation of larger ice crystals 
would consequently lead to larger pores after lyophilization [100]. 
Guang et al reported modification of PCL porous scaffolds by SF. Scaffold morphology 
was altered due to the presence of silk fibroin, whereby increasing cell adhesion and 
metabolism. Liu et al studied the application of polyurethane and SF films in controlling the 
release of heparin. The presence of SF improved the release of heparin from the SF films 
[101]. Li et al analyzed the role of BMP-2 in improving the osteogenic properties of SF 
nanofibers. Improved osteoconductivity was noted in the BMP modified scaffolds [102]. 
Lee et al found that alginate improved the various material properties of SF based sponges 
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[103]. Yang et al analyzed the role of cellulose combined with SF and their post treatment 
with alkali [104].  
SF/CS blends have been utilized for many tissue engineering applications (table 2.2). 
She et al has studied the in vitro degradation properties of SF/CS porous scaffolds.Mass % 
loss of scaffolds was found to be 19.28 wt% after 8 weeks of degradation [15]. Gobin et al 
explained the mechanical and structural properties of SF/CS porous scaffolds [69]. Altman 
et al described the in vitro studies on SF/CS scaffolds using human adipose tissue derived 
stem cells. They also explained the adhesion, migration and mechanics of human adipose-
tissue-derived stem cells on these scaffolds. Enhanced wound healing and differentiation of 
adipose derived stem cells was observed on silk chitosan scaffold [28]. Bhardwaj studied 
the blend of SF/CS in preparing porous scaffolds and their characterization for tissue 
engineering applications [23]. They have also analyzed the potential of this scaffold blend 
for the culture of bovine chondrocytes and also rat derived chondrocytes. The scaffolds 
facilitated mesenchymal stem cell attachment, migration, cell–cell interaction and 
differentiation [27]. Zeng et al explained in detail the various blend ratios of SF/CS scaffolds 
for bone tissue engineering applications. The 40% SF-60% CS group proves the preferred 
ratio of scaffold material for bone tissue engineering [106]. 
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Table 2.2: Silk Fibroin/Chitosan blends in tissue engineering applications 
Biomaterials Type of 
scaffold 
SF/CS 
blend ratio 
Observation Ref 
Silk fibroin & 
Chitosan 
Film 50:50 
Polymer induced conformation change observed 
with addition of chitosan to silk fibroin 
[18] 
Silk fibroin & 
Chitosan 
Scaffold 1:1 
Weight loss of scaffolds 19.28 wt% after 8 weeks 
of degradation 
[17] 
Silk fibroin & 
Chitosan 
Scaffold 75:25 
Enhanced wound healing and differentiation of 
adipose derived stem cells on silk chitosan scaffold 
[28] 
Silk fibroin & 
Chitosan 
Scaffold 50:50 
Interconnected porous structure, mechanical 
properties, for soft tissue engineering 
[16] 
Silk fibroin & 
Chitosan 
Scaffold 75:25 
Facilitates mesenchymal stem cell attachment, 
migration &cell–cell interaction 
[29] 
Silk fibroin & 
Chitosan 
Scaffold 1:1 
Scaffolds supported cell attachment and growth, 
and differentiation 
[76] 
Silk fibroin & 
Chitosan 
Scaffold 1:1 MSC based cartilage repair [27] 
Silk fibroin & 
Chitosan Scaffold 
20:80, 
40:60, 
60:40, 
80:20 
The 40% silk fibroin-60% chitosan group proves 
the preferred ratio of cell scaffold material 
[106] 
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In recent years, cartilage tissue engineering has been emerged as the most promising 
technique for the regeneration of cartilage tissue defects due to trauma and diseases through 
the development of biologically active 3D artificial extracellular matrix i.e tissue engineered 
scaffold. The design and fabrication of these scaffolds with a set of desired properties is the 
most challenging task. Among the various natural biopolymer, SF is considered as one of 
the potential candidates owing to its biocompatibility, biodegradability, non-immunogenic 
and robust mechanical properties [16]. However, SF lacks in hydrophilicity and delayed 
degradation which limits application for cartilage tissue engineering. CS, a partially de-
acetylated product of chitin, is biocompatible, biodegradable and has excellent wound 
healing property [17]. Moreover, the inherent glycosaminoglycan residues of CS can aid in 
supporting cartilage tissue growth [27]. However, the rapid degradation rate and low 
mechanical strength warrants its application in tissue engineering [16,17]. Therefore, the 
present research focuses on the development of an optimal ratio of SF/CS blend and SF/CS 
based hybrid scaffold with bioactive molecules for cartilage tissue application.  
 
3.1 Objectives 
The objectives of the research work are as follows 
 
i. To develop porous scaffolds from silk fibroin/chitosan polymer blends by freeze 
drying method 
ii. To improve the properties of SF/CS scaffolds by incorporating bioactive molecules 
iii. To study physico-chemical and mechanical properties of the scaffolds 
iv. To study in vitro biocompatibility of the scaffold  
 
3.2 Scope of the work 
Cartilage is an integral part of the soft tissue matrix that aids the functioning of the joints. 
Progressive wear and tear, along with trauma leads to joint degeneration. Unlike other types 
of tissue, cartilage does not have its own blood supply and is aneural. Therefore, after injury, 
cartilage is much more difficult to self-heal and requires to be replaced completely. As a 
rapidly expanding field, tissue engineering may provide alternative solutions for articular 
cartilage repair and regeneration through development of tissue engineered scaffold. 
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In this context, the main challenge is the design and fabrication of a 3D scaffold as 
artificial ECM from a suitable biopolymer or polymer composites by an appropriate method 
to replace the cartilage tissue.  
From the literature review, we can understand that the porous scaffolds have a potential 
for cartilage tissue engineering. SF and CS blends have been utilized for cartilage 
regeneration.However, in most of these studies, a specific ratio of SF/CS was used with the 
aim of exploring the suitability of the blend as scaffold material except the study of [106] 
on the effect of blend ratio targeting bone tissue engineering application. Therefore, the 
present work offers detail study on the influence of SF/CS blend ratio on the properties of 
scaffold targeting for cartilage tissue regeneration. Bioactive molecules like Glu and Chs 
are utilized as oral supplements for cartilage tissue regrowth. It is hypothesized that the use 
of these bioactive molecules in SF/CS blend solution for the fabrication of hybrid scaffold 
may pave the way for a potential artificial extracellular matrix for cartilage tissue 
engineering. 
 
The various scope of the research work is summarized as follows- 
 
1. Development of SF/CS blend scaffold 
 SF is an attractive fibrous protein and has many biomedical applications because of its 
permeability to oxygen and water vapor and robust mechanical strength. CS, a partially 
de-acetylated product of chitin, is biocompatible, biodegradable and has excellent 
wound healing property. Moreover, CS has its inherent glycosaminoglycan residues that 
can aid in supporting cartilage tissue growth A specific ratio of SF/CS was used with 
the aim of exploring the suitability of the blend as scaffold material by most of the 
researchers [13, 20, 21] Therefore, efforts will be given to establish the optimal blend 
ratio of SF/CS blend scaffold on the properties of scaffold targeting for cartilage tissue 
regeneration 
2. Characterization of scaffold 
It is necessary to assess physicochemical, mechanical and biological properties of 
the scaffold to find their suitability for cartilage tissue engineering. The scaffold 
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property such as morphology, hydrophilicity, porosity, compressive strength will be 
characterized. The cell supportive property in terms of cell adhesion, cell proliferation 
and secretion of cartilage specific ECM will be evaluated. 
3. Development of silk fibroin/chitosan/glucosamine sulfate scaffolds 
Cartilage tissue comprises of a proteoglycan rich network which contains Glu, which 
acts as the backbone of proteoglycan chain. It is evident from the literature that 
glucosamine sulfate is usually used as an oral supplement for the regeneration of 
cartilage tissue [20]. Hence the cell binding affinity of the SF/CS blend scaffold shall be 
improved by addition of Glu in the SF/CS blend to form the hybrid scaffold. Glu can be 
beneficial in facilitating the cartilage specific ECM formation through GAG synthesis. 
The developed hybrid scaffolds will be characterized for its physicochemical and 
biological properties.  
4. Development of silk fibroin/chitosan/chondroitin sulfate scaffolds 
 Like glucosamine sulfate, Chs is also used as an oral supplement for the regeneration 
of cartilage tissue. Chs is one of the naturally occurring GAGs present in the aggregan 
region of the cartilage tissue [80]. It is an important component of extracellular matrix. 
The anti-inflammatory activity, water and nutrient absorption activity, wound healing 
property and bioactivity at the cellular level of Chs are beneficial for cartilage tissue 
engineering [23]. In this context, Chs will be added to SF/CS blend scaffold to 
investigate the effect of Chs on the SF/CS scaffold property.  
 
5. Development of silk fibroin/chitosan/glucosamine sulfate/chondroitin sulfate 
scaffolds 
Glu and Chs in combination are widely used for the regeneration of cartilage tissue using 
1500/1200 mg of Glu and Chs respectively which reduced pain, improved the strength 
and movement of older prople. The synergistic effects of both Glu and Chs towards 
cartilage regeneration was also reported [25]. The combination of Glu and Chs has 
alleviated pain, discomfort and improved the overall joint function in the patient groups. 
To make the SF/CS scaffold more effective towards cartilage tissue regeneration, cell 
supportive property will be improved by adding Glu and Chs together in SF/CS scaffold. 
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The combined effect will be assessed by physicochemical, mechanical and biological 
properties. 
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4.1 Materials 
4.1.1 Chemicals for scaffold fabrication 
Silk cocoons (Bombyx mori) were purchased from Sericulture training institute, 
Nanjikottai, Thanjavur, Tamilnadu (India). Chitosan (degree of deacetylation > 85%), 
Na2CO3, CaCl2, HCOOH, C2H5OH, CH3COOH and Na2HPO4 were procured from Merck, 
India. Glucosamine sulfate, chondroitin sulfate, NaCl, KCl, CaCl2, MgCl2, K2HPO4, 
NaHCO3 and Na2SO4 were procured from Sigma Aldrich (USA) and used without any 
further purification. 
4.1.2 Chemicals for cell culture study 
Dulbecco’s modified eagle medium (DMEM), penicillin-streptomycin solution, 
chondrogenic basal media with supplement, phosphate buffered saline (PBS) and trypsin 
were purchased from Gibco (BRL, USA). Fetal bovine serum (Hi-FBS), MTT reagent assay 
kit, EDTA was purchased from Hi-media. Gluteraldehyde, paraformaldehyde, papain, 
cysteine, 1, 9-dimethylmethylene blue (DMMB) were procured from Sigma Aldrich. Quant-
it Pico green DNA kit was purchased from Thermofischer. Hoescht and TRIT-C Phalloidin 
were purchased from Invitrogen. 
4.2 Methods 
4.2.1 Preparation of regenerated SF powder 
The silk cocoons were cut into fine pieces and cleaned to remove any debris. SF was 
extracted from the cocoons by a process called degumming in which the cut cocoon pieces 
are boiled in 0.02 M sodium carbonate solution for 30 mins. SF fibers thus obtained were 
washed thrice with distilled water and dried overnight at 40°C. The fibers were later re-
dissolved in Ajisawa’s reagent [CaCl2:H2O: EtOH (1:8:2)] [115].The SF solution was 
dialyzed for 3 days against deionized water using Slide-a-Lyzer dialysis cassette (Pierce, 
Thermo Fischer, MWCO 3500). The solution was then frozen at -80°C for 5 hours followed 
by freeze drying (lyophilization) for 3 days [123]. B.mori SF powder thus obtained was 
stored in an air tight container until further use. 
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4.2.2 Preparation of SF porous scaffolds by freeze drying method 
Regenerated SF powder was dissolved in 0.1M HCOOH solution to obtain 2wt% SF 
regenerated solution. The solution was poured into plastic petridishes of size 60 mm and 
frozen at -20°C. The frozen samples were lyophilized at -110°C with 480 torr for 3 days to 
obtain freeze dried scaffolds [106].  
4.2.3 Preparation of SF/CS blend porous scaffolds by freeze drying 
method 
CS was dissolved in aqueous 0.1M CH3COOH solution to form 2.5 wt% of polymer 
solution. SF and CS solutions were mixed in various volume ratios namely 90:10 (v/v), 
80:20 (v/v), 70:30 (v/v), 60:40 (v/v) and 50:50 (v/v) to prepare homogeneous solutions [69]. 
Then the above mentioned procedure was followed to prepare SF/CS blend porous freeze 
dried scaffolds. 
4.2.4 Preparation of SF/CS/Glu scaffolds 
Glu solutions with different concentration namely 0.2, 0.4, 0.6, 0.8, 1 & 1.2 wt% were 
prepared. 1 ml of the prepared solutions was added to 20 ml of SF/CS blend solution and 
kept for stirring overnight, at room temperature, and finally the scaffolds were prepared by 
freeze drying method. The developed scaffolds are designated as SF/CS/Glu. 
4.2.5 Preparation of SF/CS/Chs scaffolds 
Chs solutions with different concentration namely 0.2, 0.4, 0.6, 0.8, 1 & 1.2 wt% were 
prepared with varying concentrations. 1 ml of the prepared solutions was added to 20 ml of 
SF/CS blend solution and kept for stirring overnight, at room temperature, and finally the 
scaffolds were prepared by freeze drying method. The developed scaffolds are designated 
as SF/CS/Chs. 
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4.2.6 Preparation of SF/CS/Glu/Chs scaffolds 
Chs solutions with different concentration namely 0.5, 1.0 and 1.5 wt% were prepared. 1 ml 
of the prepared solutions was added to the solution of SF/CS/Glu, which was prepared by 
mixing 1% Glu in SF/CS (80:20) blend solution and kept for stirring at room temperature 
overnight. Scaffolds were developed using freeze drying method. 
4.3 Characterization of scaffolds 
4.3.1 Morphological characterization 
Morphology and pore structure of the developed scaffolds were analyzed using a Scanning 
Electron Microscopy (SEM) [JEOL-JSM 6480 LV]. The traces of moisture present in the 
scaffold samples was removed by drying them using a vacuum drier for 1 hr at 40°C. The 
scaffolds were cut into small pieces and coated with platinum using polar on range sputter 
coater before imaging. The pore size of the developed scaffolds was measured by using 
Image J (USA) software [16].  The average pore size was determined by measuring 20 pores 
selected randomly through graphical measurement on SEM image. 
4.3.2 Porosity and pore distribution 
The distribution of pore size and porosity of the scaffolds were performed using Mercury 
intrusion porosimeter [(Quantachrome instruments: Pore master series, USA)] with mercury 
intrusion under an increasing pressure from 0.827 to 30000 psi. The instrument was 
degassed to remove all air from it before the intrusion of mercury. The bulk density of the 
scaffolds was measured by liquid displacement method using ethanol, before actual porosity 
analysis. The determination of porosity was based on the relationship between the applied 
pressure and the pore diameter into which mercury intrudes, according to the Washburn 
equation Washburn equation: (1/ )4 (cos )D P   . All experiments were carried out in 
triplicate [107]. 
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4.3.3 Structural analysis 
FT-IR spectroscopy 
The structural property, molecular composition and functional groups of the developed 
scaffolds were evaluated by Fourier transform infrared spectroscopy (FT-IR) using an Infra 
red Microscope [Shimadzu AIM-8800, Japan]. Approximately 1 mg of each sample was 
mixed with specific amount of dry KBr powder and pelletized by using a Hydraulic press 
to create pellets of size about 10mm. The pellets were prepared as transparent disks which 
were utilized for the IR measurements. The equipment was operated in transmittance mode 
with wavelength from 500 to 4000cm-1 with a resolution of 8cm-1 [15]. 
4.3.4 Contact angle measurement 
The contact angle of the developed SF and SF/CS based scaffolds (films) was measured by 
a contact angle meter K100MK3 tensiometer (KrussGmbH, Hamburg, Germany). Films 
were prepared for the contact angle measurement by solvent casting method. Films of width 
(15mm), height (10mm) and thickness (1mm) were used for the contact angle analysis. 
Water was used as the solvent. All the samples were analyzed at room temperature in 
triplicates [108].  
4.3.5 Swelling behavior 
Swelling ability of the developed scaffolds was evaluated in SBF till they reach equilibrium, 
at regular time intervals namely 1 hr, 3 hrs, 5 hrs, 7 hrs, 24 hrs and 42 hrs. The weight of 
the samples before immersion in water DRYwt and after immersion at particular time point 
is denoted WETwt were noted. The formula used to determine % swelling of developed 
scaffold is given below [109]. 
% ( ) / 100wt wt wtSwelling WET DRY DRY                ................... (1) 
4.3.6 Biodegradation study 
 
Degradation of the developed scaffolds was performed in SBF. The initial dry weight (Wo)  
of the sample was weighed and soaked in SBF for predetermined time intervals of 1, 7, 14 
and 28 days. The sample was removed from SBF at regular time intervals and freeze dried 
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followed by weighing final weight Wt.  The remaining weight % (WR) was calculated using 
the below given formula. All the experiments were performed in triplicates [110]. 
% 100 [( ) / 100]o t oWeight remaining W W W    ………………… (2) 
4.3.7 Compressive strength 
The compressive strength of the prepared scaffolds was performed by using Universal 
testing machine (H10 KS Tinius Olsen USA). The cylindrical samples with a dimension of 
10 mm diameter and a thickness of 8 mm were used for analysis. A crosshead speed of 1 
mm/min with a load cell of 1000N was used for compression tests. All the experiments were 
performed at room temperature in triplicates. Compressive strength was calculated by using 
the formula max /S F A , where Fmax represents the force applied and A is the cross sectional 
area of the sample [16]. 
4.3.8 In-vitro cell study 
Isolation and culture of MSCs 
Umbilical Cord Blood was collected from Ispat General Hospital (IGH Rourkela), India 
with prior consent of the patient. Ficoll Hypaque technique was used to isolate mononuclear 
cells (MNCs) as described elsewhere [30, 31]. The isolated MNCs were cultured in 
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum, 
100U/ml penicillin and 0.1 mg/ml streptomycin. The culture condition maintained was 37 
0C, 5% CO2 with 80% relative humidity. MSCs were separated from non-adherent cells in 
culture flasks by discarding non adherent cells based on their unique adherent property. The 
adherent cells consisting of MSCs were washed thoroughly with PBS/EDTA and 
supplemented with freshly prepared medium. The cells were sub-cultured upto 5th passage 
by changing the media thrice in a week [33]. 
Cell seeding and culturing 
Scaffolds (9x9x2mm) were sterilized prior to cell seeding by soaking in 70% ethanol 
followed by UV treatment and sterile PBS wash. Cells from 4th passage were seeded on 
sterilized scaffolds with a seeding density of 2 × 104 cells/ml by static method.The cell 
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seeded scaffolds were incubated in a CO2 incubator with 5% CO2 at 37°C. The culture 
medium was replenished once in every two days [34]. 
Cell morphology and cell attachment 
Human mesenchymal stem cell (hMSCs) seeded scaffolds were treated with 2% (v/v) 
gluteraldehyde for fixing the cells. The samples were rinsed with wash buffer and 
dehydrated with series of ethanol gradations (50, 70, 80, 95 and 100%) for 5 min each [29]. 
Finally the samples were dried at 37°C and sputter coated with platinum for 30 sec prior to 
imaging. (Quorumtech, Q150RES, Czech Republic). Images were taken by Field Emission 
Scanning Electron Microscopy (FE-SEM) [Nova SEM-Czech Republic] in high vacuum at 
5 kV. 
Measurement of metabolic activity (MTT assay) 
The metabolic activity of hMSCs cultured on the developed scaffolds was evaluated 
quantitatively by MTT [3-(4, 5-dimethylthiazol-2-yl)-diphenyltetrazolium bromide] assay 
[16]. Fresh media consisting of 100μl MTT solution (diluted in 1:10 PBS) was 
supplemented to the cells. After incubation at 37°C for 4 hrs, 0.5 ml DMSO was added to 
the cells and centrifuged at 1000 rpm for 5 min. The optical density (O.D) of the pink 
colored formazan derivative was measured using a spectrophotometric plate reader (2030 
multi label reader Victor X3, Perklin Elmer, USA) at 595 nm [16]. 
Cell viability analysis by live and dead assay 
The scaffolds were rinsed with 0.1M PBS for 20 min. The samples were later stained using 
calcein-AM dye and kept under incubation for a period of 30 min. The samples were 
removed, washed with PBS and observed under fluorescence microscope (Carl Zeiss, 
Axiovert 40CFL) [111]. 
Cell proliferation by DNA quantification measurement  
hMSC proliferation on the prepared scaffolds was analysed by DNA quantification assay. 
In brief, cell seeded scaffold constructs were incubated at specific time periods upto 21 days 
in complete DMEM media supplemented with 10% fetal bovine serum, 100U/ml penicillin 
and 0.1 mg/ml streptomycin in a 12 well tissue culture plate. The cell scaffold constructs 
were rinsed with DMEM and PBS repeatedly followed by lysis with 0.5 ml of Lysis buffer 
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(10 mM tris and 2% triton) for 1 hr. The cell lysate was sonicated. 100 µL of Quant-it 
PicoGreen reagent was added to equal amount of sonicated cell lysate and incubated at 37°C 
for 10 mins. The excitation and emission wave lengths of fluorescence were 528 nm and 
485 nm respectively. The readings were then compared with the number of cells with the 
help of a calibration curve created with known concentration of hMSCs [111]. 
Cell distribution and cytoskeletal organization  
Confocal laser scanning microscopy was used to analyse the cell distribution and 
cytoskeletal analysis of hMSCs on the developed scaffolds. Hoescht and Trit C Phalloidin 
were used according to the protocol followed elsewhere. Briefly, cell seeded scaffolds after 
7 and 14 days of study were harvested and fixed with 4% paraformalydehyde solution. 
Permeabilization with Triton X was performed followed by PBS wash. Hoechst nuclear 
stain was then performed for a minute and the constructs were further stained with TRIT C 
conjugated Phalloidin. The samples were examined by confocal laser scanning microscope 
(Olympus IX 81) [96]. 
Estimation of GAG (Glycosamino glycan) 
The scaffolds seeded with hMSCs were cultured in freshly prepared chondrogenic 
differentiation media. The cell seeded scaffolds were incubated in a CO2 incubator with 5% 
CO2 at 37°C. The culture medium was replenished once in every two days. 
GAG content of the cell seeded scaffolds was evaluated by GAG assay using the 1, 9-
dimethylmethylene blue (DMMB) reagent. At specific time intervals, GAG was harvested 
from the cells by digestion with papain solution (125 μg/mL of papain, 5 mM L-cystein, 
100 mM Na2HPO4, 5 mM EDTA) maintaining a pH of 6.8 at 60°C for 16 hrs. Absorbance 
was measured at 525nm [112]. 
4.4 Statistical analysis 
Statistical analysis of data was performed with ANOVA considering p<0.05 as statistically 
significant. All data is presented as mean ± standard deviation with n = 3. 
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SF is a fibrous protein and has many biomedical applications because of its permeability to 
oxygen and water vapor and robust mechanical strength [9]. However, because of its slow 
degradation, brittleness and lack of hydrophilicity, its use in tissue engineering is limited 
[17]. CS, a partially de-acetylated product of chitin, is biocompatible, biodegradable and 
has excellent wound healing property [16]. Moreover, CS has its inherent 
glycosaminoglycan residues that can aid in supporting cartilage tissue growth [16]. 
However, the rapid degradation rate and low mechanical strength warrant its application in 
tissue engineering [111]. Therefore, the use of SF or CS alone is not suitable as scaffold 
material. Therefore, a number of researchers have given effort to study the effect of 
combination of these two natural polymers and reported the resultant blend with excellent 
scaffold properties [69,77]. However, in most of these studies, a specific ratio of SF/CS was 
used with the aim of exploring the suitability of the blend as scaffold material [27,69,76,77] 
except the study of Zeng. et. al on the effect of blend ratio targeting bone tissue engineering 
application [106].  
Therefore, efforts are given in this phase of dissertation to develop SF/CS blend 
scaffolds by freeze drying method. The influence of volume ratio of SF/CS on various 
scaffold properties is investigated by physicochemical, mechanical and biological 
characterizations, targeting for cartilage tissue regeneration.The resultsand discussion of 
this experimental is presented in this chapter. 
5.1 Results and Discussion 
5.1.1 Scanning electron microscopy (SEM) 
Sufficient pore size and pore interconnectivity are important for the supply of nutrient and 
oxygen to the cells and also for the release of wastes [48]. Figure 1 shows the SEM images 
of the developed freeze dried pure SF and SF/CS blend scaffolds. As it is seen in figure, all 
the scaffolds possess open microporous structures with varying pore sizes and high pore 
interconnectivity. Table 5.1 shows the pore size and average pore size of the developed 
scaffolds. A gradual increase in average pore size from 95 ± 25.2 to 230 ± 20.4 µmwas 
observed with increase in CS content in the scaffold. The pore size of scaffold depends on 
the formation of ice crystal which results from the water content of the polymeric blend 
[29]. CS, being a hydrophilic polymer, increases the water content during freezing process 
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thereby forms large ice crystals which in turn create large pores upon sublimation during 
freeze drying. The measured pore sizes of the developed scaffolds are within the desired 
range of pore size suitable for cartilage tissue engineering [113]. The increase in pore size 
with increase in CS volume in SF/CS blend scaffold has also been reported earlier [16]. 
 
 
Figure 5.1: SEM images of (a) Pure SF, (b) SF/CS (90:10), (c) SF/CS (80:20), (d) SF/CS (70:30), 
(e) SF/CS (60:40) and (f) SF/CS (50:50) scaffolds. All scaffolds possessed open porous 
microstructure with desired pore size and interconnected pores. 
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5.1.2 Porosity 
Porosity of scaffold is an important parameter in tissue engineering. The higher porosity 
provides higher cell proliferation, cell migration and fosters nutrient delivery [107]. Both 
pure SF and SF/CS blend scaffolds exhibit porous structures with desired porosity. Table 
5.1 shows the porosity of the SF and SF/CS blend scaffolds. Pure SF scaffolds exhibited 
maximum porosity of 93.3±1.6%. The porosity of the SF/CS blend scaffold was decreased 
with increase in CS content. Among the prepared blend scaffolds, the maximum porosity 
(87.9±1.2%) was observed with the scaffold having SF/CS volume ratio of 90:10, followed 
by 80:20. The hydrophilic nature of CS increased the water content of the scaffolds, creating 
bigger pores thus offered decreased porosity, which was also reported earlier [16]. However, 
the prepared blend scaffold still possess adequate porosity and thus suitable for tissue 
engineering applications. 
 
Table 5.1: Pore size range, average pore size and porosity of pure SF and SF/CS blend scaffolds 
Sample Pore size (µm) Average pore size (µm) Porosity (%) 
SF 45-122 95 ± 25.2 93.3±1.6 
SF/CS (90:10) 52-165 155 ± 30.3 87.9±1.2 
SF/CS (80:20) 71-201 186 ± 32.2 82.2 ±1.3 
SF/CS (70:30) 78-221 202 ±26.1 78.0±1.9 
SF/CS (60:40) 84-229 216 ± 23.5 73.5±2.8 
SF/CS (50:50) 91-236 230 ± 20.4 71.2±2.0 
 
5.1.3 Structural analysis 
FT-IR spectroscopy 
Fourier transform infrared spectroscopy is a useful tool in determining the interactions 
between the various chemical groups present in the blend solutions. Figure 5.2 represents 
the FT-IR spectra of SF, CS and SF/CS blend scaffolds. FT-IR spectra reveals that the amide 
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V absorption band at 700 cm-1, amide III band at 1260 cm-1, amide II band at 1525 cm-1and 
amide I band at 1625 cm-1 relate to the β sheet conformation of SF. Whereas the band at 
1598 cm−1 corresponds to the amino group of CS. The additional band at 1080cm−1 in SF/CS 
blend scaffolds is the characteristic band of the SF/CS blend scaffold [16].  
 
Figure 5.2: FT-IR spectrum of (i) Pure SF, (ii) SF/CS (90: 10), (iii) SF/CS (80:20), (iv) SF/CS (70: 
30) and (v) Pure CS scaffolds. SF/CS blend scaffolds showed characteristic band of SF/CS at 
1080 cm−1. 
 
5.1.4 Swelling behavior and water contact angle 
The swelling behavior of scaffolds enables the cells to utilize the interior architecture of the 
scaffold to a maximum extent [18]. The swelling ability of a scaffold is essential to support 
numerous cellular activities. Figures 5.3 shows the % swelling of pure and blend scaffolds. 
Pure SF scaffold showed the least swelling behaviour (~204 %) when compared to the 
SF/CS blend scaffolds. Swelling was found to increase with increase in CS content (~222-
262 %), as shown in figure 5.3.The increase in swelling ratio is attributed to the increase in 
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hydrophilic CS. Similar trend in swelling behavior of SF/CS blend scaffolds were reported 
earlier in the literature [17,18].The percentage of swelling was found to increase with an 
increase in CS content (Fig. 5.3), which may be partly due to the increase in pore size 
thereby enhancing the water uptake capacity [17] and partly due to increased hydrophilicity 
of the scaffold material. Change in swelling ability with different volume ratios of silk 
fibroin and chitosan is due to the varying amounts of chitosan which is hydrophilic in nature. 
The intermolecular interaction between silk fibroin and chitosan changes with difference in 
chitosan percentage. SF, being a fibrous protein, exhibits less hydrophilicity due to the 
presence of β-sheet conformation. CS has a unique structural feature that is the presence of 
a primary amine at the C-2 position of the glucosamine residues. CS has improved water 
uptake capacity due to the presence of a high content of primary amines [15]. Further, due 
to its more degradation ability than SF, greater CS content will hampers the stability of the 
blend scaffolds in water [17]. 
However, the contact angle of water measured on SF/CS scaffold decreased from 55.3± 
0.1° to 51.5 ± 1.2° on increasing CS from 10 to 50 (v/v) as compared to pure SF scaffold 
(56.2 ± 0.2°), as shown in table 5.2. This further supports the high hydrophilicity of SF/CS 
blend scaffolds that increases with increase in CS content and thereby possess superior 
surface property. 
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Figure 5.3 Swelling behaviour of (a)  Pure SF scaffolds, (b) SF/CS (90:10), (c) SF/CS (80:20), (d) 
SF/CS (70:30), (e) SF/CS (60:40) and (f) SF/CS (50:50). Pure SF scaffold showed the least swelling 
behaviour when compared to the SF/CS blend scaffolds. Swelling was found to increase with 
increase in CS content. 
 
Table 5.2: Contact angle of SF and SF/CS scaffolds. 
Sample Contact angle(degree) 
SF 56.2 ± 0.2 
SF/CS (90:10) 55.3± 0.1 
SF/CS (80:20) 54.2±0.3 
SF/CS (70:30) 53.6 ± 0.8 
SF/CS (60:40) 52.5 ± 0.6 
SF/CS (50:50) 51.5 ± 1.2 
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5.1.5 In-vitro degradation 
The ability of a scaffold material to degrade with time, inside a biological system is a 
promising feature in order to facilitate growth of neo tissue [14]. Nevertheless, an optimum 
degradation rate is essential which needs to match the growth rate of the new tissue and 
sustainability at the site of implant [15]. Figure 5.4 presents the in-vitro degradation of the 
pure SF and SF/CS blend scaffolds. Pure SF, being a less hydrophillic polymer, shows a 
very slow and stable degradation, with 93.2% remaining after 28 days of study. As the 
volume ratio of CS was increased, the degradation behaviour also shifted to a faster pace, 
owing to the water absorbing nature of chitosan [15]. Blends of 90:10 and 80:20 SF/CS 
show residual % mass remaining of 88 %and 87.9 % respectively followed by 70:30 and 
60:40 with 84 and 82 % in 4 weeks. The least mass remaining is observed with the blend 
ratio of 50:50 where 76% of the total mass was present. The number of hydrogen bond 
interactions between SF and CS increases with CS, which enhances the tendency to attract 
water molecules towards them, thereby causing rapid degradation [17]. 
 
Figure 5.4: Degradation pattern of (a) Pure SF, (b) SF/CS (90:10), (c) SF/CS (80:20), (d) SF/CS 
(70:30), (e) SF/CS (60:40) and (f) SF/CS (50:50) scaffolds. Faster degradation was observed with 
increase in chitosan content. 
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5.1.6 Compressive strength 
Compressive strength is one of the properties which is used to assess whether the scaffolds 
possess sufficient strength to cater the stress imparted by the native tissue formed 
[35].Figure 5.5 shows the compressive strength of both pure SF and SF/CS blend scaffolds. 
In comparison to pure SF (160±0.3 kPa), a higher compressive strength of 210±0.9 kPa was 
obtained by addition of CS to SF with 90:10(v/v) blend ratio (fig.5.5). However, a gradual 
decrease in compressive strength was observed with increase in CS in blend. The initial 
increase in compressive strength as observed with SF:CS (90:10), may be attributed to 
the strong ionic bond formation between SF with a lesser amount of CS. But as CS 
increased, the formation of weaker ionic interactions occurred and consequently, 
compressive strength decreased. A similar trend in compressive strength was also reported 
earlier [116].Overall, the compressive strength of the developed scaffolds is within the range 
of 0.01-3MPa suitable for cartilage tissue engineering application [116]. 
 
Figure 5.5: Compressive strength of (a) Pure SF, (b) SF/CS (90:10), (c) SF/CS (80:20), (d) SF/CS 
(70:30) (e) SF/CS (60:40) and (f) SF/CS (50:50) scaffolds. A gradual decrease in compressive 
strength was observed with increase in chitosan content. 
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5.1.7 In vitro cell culture study 
Morphological study of hMSCs 
Figure 5.6 shows the phase contrast microscope images of hMSCs after 1st week, 3rd week, 
5th week and 7th week of culture. The isolated MSCs were cultured in DMEM media upto 
4th passage. Initially, during the first week of culture, the cells were round in morphology. 
In subsequent passages, the cells slowly attained elongated morphology, which is a 
characteristic feature of hMSCs. At the end of 3rd passage, it was observed that all the cells 
acquired the desired morphology of hMSCs. These were maintained and used for further in- 
vitro cell culture studies. 
 
 
Figure 5.6:Morphological changes of hMSCs observed under phase contrast microscope during (a) 
1stweek, (b) 3rdweek (c) 5th week and (d) 7th week of culture. Initially the cells are found to be 
spherical in shape and slowly reached fibroblast like morphology in about 7 weeks of culture 
 
Cell morphology and cell attachment 
Cell attachment and cell morphology study generally indicate the cordial relationship 
between the seeded cells and the scaffold environment. It is, therefore, important to analyze 
the suitability of the biomaterial towards cellular behavior in culture condition. SEM 
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micrographs in Figure 5.7 shows the attachment and spreading of MSCs on the scaffold 
during 7 (a-d) and 14 (e-h) days of culture. Cells were found to be initially adhered to the 
scaffold matrix. With increase in culture time, the hMSCs were found to spread well 
throughout the SF/CS (80:20) blend scaffold representing its superior cell supportive 
property than the other blend scaffolds (Figure 5.8). A slightly lower cell density was 
observed with increase in CS content in the SF/CS (70:30) blend which may be due to the 
lower porosity of the scaffold resulting in lower volume that decreased the cell migration 
and nutrient delivery [114]. 
 
 
Figure 5.7: FE-SEM images for cell attachment and proliferation of hMSCs over various scaffolds. 
(a) and (e) Pure SF, (b) & (f) SF/CS (90:10), (c) & (g) SF/CS(80:20) and (d) & (h) SF/CS (70:30) 
scaffolds after 7 and 14 days of culture respectively. hMSCs were found to spread well throughout 
the SF/CS (80:20) blend scaffold representing its superior cell supportive property than the other 
blend scaffolds. 
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Figure 5.8: Magnified FE-SEM image showing cell proliferation over SF/CS (80:20) blend scaffolds 
after (a) 7 days and (b) 14 days of culture. 
 
Cellular metabolic activity by MTT assay 
The metabolic activity of hMSCs seeded on scaffolds is a direct recognition of their ability 
to express progress as a living entity [111]. Relative cellular metabolic activity for various 
SF/CS blend scaffolds was measured by MTT assay at 3, 5 and 7 days of culture as shown 
in fig 5.9. In comparison, SF/CS (80:20) scaffold showed higher proliferation compared to 
the 70:30 and 60:40 scaffolds (p<0.05) (Figure 5.9). This may be attributed to the fact that 
there is more distinct interaction between the positive amino groups of chitosan and the 
negative charges located in the cells. The 80:20, 70:30 and 60:40 blend scaffolds showed 
better cell proliferation in day 5 and day 7, but 80:20 blend showed more cell proliferation 
compared to the 70:30 and 60:40 blend scaffolds (p<0.05).  
The metabolic activity of SF/CS scaffold was increased with increase in CS content upto 
20% which may be attributed to the higher cell binding ability of CS than SF. However, a 
slight decrease in metabolic activity was observed with further increase in CS content in the 
blend (SF/CS 70:30 and 60:40). The decrease in metabolic activity representing the lower 
proliferation of MSCs on these scaffolds is probably due to having lower porosity which 
has concealed the benefit of higher cell binding ability of CS. The decreased cell 
proliferation may be attributed to reduced pore volume that resulted in lower cell migration 
and nutrient delivery on to the scaffold [111,114]. 
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Figure 5.9: Cell viablility analysis by MTT assay on (a) SF, (b) SF/CS (90:10) blend, (c) SF/CS 
(80:20), (d) SF/CS (70:30) and (e) SF/CS (60:30) blend scaffolds. * represents significant 
differences at p <0.05. The metabolic activity of SF/CS scaffold was increased with culture time 
compared to pure SF. The metabolic activity of SF/CS scaffold was increased with increase in CS 
content upto 20% and thereafter, a slight decrease in metabolic activity was observed with further 
increase in CS content in the blend 
 
Cell viability studies by live/dead assay 
Cell viability study is crucial to determine the biocompatibility of the developed scaffold 
matrices. Increased growth of cells over culture time signifies the non-cytotoxic behavior 
of the cell supportive material [111]. Figure 5.10 represents the live/ dead assay of SF and 
SF/CS blend scaffolds. When compared to pure SF scaffolds, SF/CS (80:20) blend scaffolds 
showed increased cell viability which is due to the increased percentage of cell supportive 
domains in the blend scaffolds [111].  
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Figure 5.10: Live and dead assay on (a) and (c) SF scaffold; (b) and (d) SF/CS (80:20) scaffold. (a) 
and (b) represent 5 days and (c) and (d) represent 7 days after cell seeding. SF/CS (80:20) blend 
scaffold shows increased cell viability when compared to pure SF scaffold. 
 
GAG estimation 
The presence of GAG secretion is a clear indication of the differentiation of hMSCs into 
chondrogenic lineage [96]. Figure 5.11 shows the GAG content in SF/CS (80:20) scaffolds 
and pure SF scaffolds used as control. The amount of GAG secreted by MSCs seeded on 
the SF/CS scaffolds (18µg/mg of scaffold) is higher than the pure SF scaffolds (14µg/mg 
of scaffold) (p<0.05). The presence of glycosaminoglycan groups in CS has promoted 
chondrogenic differentiation of hMSCs over blend scaffolds that lead to improved GAG 
production [27]. This study validates synergistic effect of both SF and CS that has directed 
cell proliferation and their consecutive differentiation towards the cartilaginous lineages. It 
has been demonstrated that the developed SF/CS scaffold with optimal blend ratio of 80:20 
is a potential scaffold material for cartilage tissue engineering applications. 
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Figure 5.11: GAG assessment of (a) SF scaffold (b) SF/CS (80:20) scaffold. * represents significant 
difference at p <0.05. The amount of GAG secreted by hMSC over SF/CS (80:20) scaffold was 
found to be higher throughout the culture period compared to pure SF scaffold. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
5.B DEVELOPMENT OF SILK FIBROIN/ CHITOSAN/ 
GLUCOSAMINE SULFATE SCAFFOLDS 
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In the previous section, SF/CS blend scaffolds with optimal blend ratio of 80:20 was 
developed by freeze drying method. The cell binding affinity which can mimic the natural 
environment of cartilage has been reported to be improved by the incorporation of active 
biomolecules [5]. Glu is a amino monosaccharide present in the cartilage tissue [26]. It has 
a major role in acting as a precursor for glycoprotein and GAG synthesis [24]. Glu is also 
usually used as an oral supplement for the regeneration of cartilage tissue. Therefore, it has 
been hypothesized that the addition of Glu might be beneficial in facilitating the cartilage 
specific ECM formation through GAG synthesis. 
The aim of the present phase of research work is to investigate the effect of Glu with 
varied content on the properties of SF/CS (80:20) scaffolds with the intention to improve 
cell viability, cell attachment and cartilage specific ECM formation ability of the SF/CS 
scaffolds. The resultsand discussion of this experimental work is described in this chapter. 
5.2 Results and discussion 
5.2.1 Scanning electron microscopy (SEM) 
SEM images has revealed that the addition of Glu does not show any negative impact on 
the morphology of SF/CS scaffold which is evident from the open and well interconnected 
porous structure (figure 5.12). Table 5.3 shows the pore size and average pore size of the 
Glu added SF/CS (80:20) scaffolds. A marginal change in pore size was observed with 
change in Glu content. The pore size and average pore size were measured to be decreased 
with increase in Glu content from 0.2 to 1.2 % (w/v). Though the pore size was lower than 
the SF/CS scaffold, the scaffold containing Glu content still possess pore size adequate for 
supporting tissue regeneration. 
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Figure 5.12: SEM images of SF/CS/Glu scaffolds with (a) (0.2), (b) (0.4), (c) (0.6), (d) (0.8), (e) (1) 
and (f) (1.2) % (w/v) of Glu respectively. All scaffolds possessed open porous network with highly 
interconnected pore structures. 
 
5.2.2 Porosity 
As observed in Table 5.3, the porosity of the SF/CS scaffold was increased with increase in 
Glu concentration, though the variation in porosity is not statistically significant between 
the concentration range. However, the maximum porosity (79.8±3.26) was achieved with 
1.2 % (w/v). A comparable porosity was also shown by scaffold with 1 % (w/v) Glu 
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(79.6±4.12). Furthermore, in comparison, the porosity of the SF/CS/Glu 1% (w/v) and 
SF/CS/Glu 1.2% (w/v) was slightly lower than the SF/CS scaffolds (control) confirming 
that the addition of Glu did not show much impact on the scaffold porosity. 
 
Table 5.3: Pore size, average pore size, and porosity of SF/CS/Glu scaffolds. 
Sample Pore size (µm) Average pore size (µm) Porosity (%) 
Glu 0.2 (w/v) 60-210 107±24.2 75.6±2.96 
Glu 0.4 (w/v) 55-204 106±18.6 76.3±3.21 
Glu 0.6(w/v) 51-200 105±30.8 76.5±3.61 
Glu 0.8 (w/v) 45-195 104±25.3 78.9±3.56 
Glu 1 (w/v) 40-190 104±19.6 79.6±4.12 
Glu 1.2(w/v) 38-184 101±23.4 79.8±3.26 
 
5.2.3 Structural analysis 
FT-IR spectroscopy 
The interaction between the functional groups present in SF/CS/Glu scaffolds was assessed 
by FT-IR spectroscopy as shown in figure 5.13. The absorption band at 1080 cm-1 suggests 
that the NH groups of SF and C=O and NH2 groups of CS have specific intermolecular 
interactions. An additional band at 1614 cm−1, which corresponds to the addition of Glu in 
SF/CS/Glu scaffolds [20,116]. The FT-IR analysis confirms the molecular interaction of 
Glu in the SF/CS blend. 
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Figure 5.13: FT-IR spectra of (a) SF/CS (80: 20), (b) Glu powder and (c) SF/CS/Glu scaffolds. The 
additional band in SF/CS/Glu scaffold is due to the interaction of Glu with SF/CS blend. 
 
5.2.4 Swelling behavior and water contact angle 
The % swelling behaviour of SF/CS/Glu scaffolds has been depicted in figure 5.14. A 
drastic increase in swelling was obtained by the addition of Glu to SF/CS (80:20) scaffold 
and the swelling rate was increased with increase in Glu content. An equilibrium state of 
swelling was observed with all the scaffolds after 10 hrs of SBF treatment. The higher 
hydrophilicity of the scaffold material was responsible for the increased swelling which was 
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resulted from the enhanced interaction between amine groups present in Glu and the 
hydroxyl groups of water [17]. The role of Glu (hydrophilic in nature) might be the main 
controlling factor in swelling which may be due to the presence of double bonds of Glu.  
The wettability and thus the hydrophilicity of the SF/CS scaffold was slightly improved 
by the addition of Glu to the scaffold as reflected from the contact angle data presented in 
table 5.4. SF/CS/Glu (0.2 -1.2 w/v) showed a decrease in contact angle in the range 53.5-
49.1°in comparison to SF/CS (80:20) (54.2±0.3°). The contact angles were found to be 
decreased in a narrow range with increase in Glu content. This decrease in contact angle is 
possibly due to the hydrophilic property of Glu that improves the wettability of the scaffold. 
Interestingly, the difference between the contact angles obtained with 1% and 1.2% Glu is 
not statistically significant representing similar hydrophilicity property of both the 
scaffolds. 
 
Figure 5.14: Swelling behaviour (a) SF/CS (80:20) blend scaffold and SF/CS with (b) 0.2, (c) 0.4, 
(d) 0.6, (e) 0.8, (f) 1 and (g) 1.2 % (w/v) of Glu respectively. A drastic increase in swelling was 
obtained by the addition of Glu to SF/CS (80:20) scaffold and the swelling rate was increased with 
increase in Glu content. 
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Table 5.4: Contact angle values of SF/CS/Glu scaffolds 
Sample Contact angle(degree) 
SF/CS (80:20) 54.2±0.3 
SF/CS/Glu 0.2 (w/v) 53.5±0.2 
SF/CS/Glu 0.4 (w/v) 52.3±0.3 
SF/CS/Glu 0.6(w/v) 51.1±0.1 
SF/CS/Glu 0.8 (w/v) 50.2±0.7 
SF/CS/Glu 1 (w/v) 49.5±0.8 
SF/CS/Glu 1.2 (w/v) 49.1±0.2 
5.2.5 In vitro degradation 
The effect of addition of Glu to SF/CS scaffold on degradation is shown in figure 5.15. It is 
observed that all the scaffolds showed a steady degradation pattern during the entire time 
period. SF/CS/Glu scaffolds were found to degrade faster in comparison to the SF/CS 
scaffolds, as shown in figure 5.15. SF/CS scaffolds showed 87.9 % mass remaining in 28 
days, whereas, the scaffolds with Glu content showed a mass remaining in the range 79-
69.4 % with varied % of Glu (0.2 - 1.2 % w/v). The reason behind the enhanced degradation 
of SF/CS/Glu scaffolds is the additional hydrophilic groups present in the scaffold due to 
addition of Glu.  
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Figure 5.15: Degradation pattern of (a) SF/CS (80:20) blend scaffold and SF/CS with (b) 0.2, (c) 
0.4, (d) 0.6, (e) 0.8, (f) 1 and (g) 1.2 % (w/v) of Glu respectivelySF/CS/Glu scaffolds were found to 
degrade faster in comparison to the SF/CS scaffolds. 
 
5.2.6 Compressive strength 
The compressive strength of the SF/CS/Glu scaffolds was measured as 199±13, 
200±17,201±13, 202±16, 202±12 and 201±10 kPa with Glu content of 0.2, 0.4, 0.6, 0.8, 1 
and 1.2% (w/v) respectively. Thus, the addition of Glu in SF/CS scaffold did not show any 
significant influence on the compressive strength that means the mechanical integrity of the 
SF/CS scaffold remain intact with addition of Glu. This may be attributed to the fact that a 
little amount of Glu added to the blend is not sufficient enough to have any impact on the 
compressive strength.  
5.2.7 In vitro cell culture 
Cell attachment and morphology 
The morphology and cellular attachment of hMSCs over SF/CS/Glu scaffolds are shown in 
figure 5.16. On close observation, hMSCs were found to attach and spread on the scaffold 
surface during the entire 14 days culture period on the scaffold. Better cell attachment is 
observed with SF/CS/Glu scaffolds in comparison to SF/CS (80:20) scaffold used as 
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control. The cells were also well spread throughout the scaffold and colony formation was 
observed on day 14. The enhanced cell attachment and spreading on scaffolds loaded with 
Glu can be attributed to the fact that Glu is the precursor of GAG formation [24], thus 
created a cell friendly microenvironment for the growth and proliferation of MSCs. The 
superior cell attachment and spreading observed with SF/CS/Glu scaffold represents its 
better cytocompatibility than the SF/CS scaffold.  
 
 
 
Figure 5.16 FE-SEM images of cell attachment and proliferation of MSCs over various scaffolds (a) 
& (b) SF/CS (80:20) scaffold, (c) & (d) SF/CS/Glu 1% (w/v) after 7 and 14 days of culture 
respectively. Superior cell attachment and spreading were observed in SF/CS/Glu scaffolds than 
SF/CS scaffolds. 
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Cellular activity by MTT assay  
The cellular viability in terms of metabolic activity of the MSCs seeded on the SF/CS/Glu 
scaffolds was evaluated by MTT assay is shown in figure 5.17. As expected, the metabolic 
activity was found to increase with the progress of the culture upto 7 days and the metabolic 
activity of SF/CS/Glu was higher than the SF/CS scaffolds. The improved metabolic activity 
shown by SF/CS/Glu can be attributed to the presence of increased Glu residues providing 
suitable cell recognition sites thereby attracted more number of cells on the scaffold surface 
[26]. Since there is no significant difference in cell viability between SF/CS/Glu scaffolds 
containing 1 and 1.2 % (w/v) of Glu, SF/CS/Glu scaffolds with 1% (w/v) was selected for 
further study. 
 
 
Figure 5.17: MTT assay of (a) SF/CS (80:20) scaffolds and SF/CS/Glu (b) 0.8, (c) 1 and (d) 1.2 % 
Glu (w/v). The metabolic activity of SF/CS/Glu scaffold increased with increase in Glu content. 
 
Cellular proliferation by DNA quantification 
A gradual increase in DNA content was observed during the progress of MSCs culturing in 
all the developed scaffolds. A higher DNA content (349 ng/ml) representing the higher 
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MSCs proliferation was obtained when SF/CS was loaded with 1% Glu in comparison to 
the DNA content shown by the SF/CS scaffold during the entire culture period of 21 days 
(fig. 5.18). The enhanced proliferation of MSCs shown by SF/CS/Glu scaffolds is due to 
the fact that Glu has facilitated a suitable microenvironment for the normal functioning of 
cell [26].  
 
 
 
Figure 5.18: Proliferation in terms of DNA quantification of hMSC over (a) SF/CS (80: 20) scaffold, 
(b) SF/CS/Glu scaffolds with 1% (w/v) Glu. The hMSC proliferation on SF/CS scaffold increased 
with addition of Glu. 
 
Cytoskeletal analysis by confocal microscopy  
Confocal microscopy is a technique used to understand the cell spreading, proliferation in 
a scaffold matrix. It also enables to study the formation of F-actin and analyze the cell-
scaffold interactions [96]. Figure 5.19 shows the uniform distribution of hMSCs on the 
SF/CS/Glu scaffolds observed under a confocal microscope. The cells were found to be well 
spread on the surface and also inside of the SF/CS/Glu scaffolds showing its superior cell 
compatibility thereby promoted cell-scaffold interaction than control (SF/CS 80:20). On the 
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14th day of culture, the number of viable cells observed is more on SF/CS/Glu scaffolds than 
SF/CS representing the higher cell proliferation shown by SF/CS/Glu scaffold due to the 
presence of disaccharide building blocks in Glu [81].  
 
 
Figure 5.19: Confocal images showing the cytoskeletal arrangement on (a) SF/CS (80:20) scaffold; 
(b) SF/CS/Glu scaffolds with 1% (w/v) Glu. The cells were found to well spread on the surface and 
also inside of the SF/CS/Glu scaffolds. 
 
 GAG estimation  
GAG estimation is an essential study which determines the ability of the cell seeded scaffold 
to support differentiation of cells to ECM synthesis [111]. The amount of GAG secreted by 
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MSCs over the SF/CS/Glu scaffolds during 21 days of culture is shown in figure 5.20. An 
increase in GAG content was observed with increase in culture time. However, GAG 
secreted by MSCs over SF/CS/Glu scaffolds was higher than the control (SF/CS) 
throughout the culture period.The corresponding amount of GAG secreted was measured to 
be 21µg/ml and 18 µg/ml for SF/CS/Glu and SF/CS (80:20) respectively. The existence of 
GAG components in the SF/CS/Glu scaffold has enabled it to support better cellular activity, 
thereby an improved GAG production was achieved. Thus, this study demonstrated that the 
presence of Glu has enhanced cell proliferation and GAG secretion representing the 
differentiation ability of the scaffold [111]. This is also supported by the study as reported 
elsewhere [27]. 
 
 
 
Figure 5.20: GAG analysis of (a) SF/CS (80:20) scaffold. (b) SF/CS/Glu scaffold with 1% (w/v) 
Glu. An increase in GAG content was observed with increase in culture time. The scaffold 
containing Glu showed higher GAG formation. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
5.C DEVELOPMENT OF SILK FIBROIN/CHITOSAN / 
CHONDROITIN SULFATE SCAFFOLDS 
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In the previous chapter, the cell supportive property such as cell metabolic activity and GAG 
producing ability of MSCs seeded SF/CS scaffold was improved by the addition of Glu as 
a bioactive molecule. Chs is one of the naturally occurring GAG present in the aggregan 
region of the cartilage tissue [21]. It is an important component of extracellular matrix. The 
anti-inflammatory activity, water and nutrient absorption activity, wound healing property 
and bioactivity at the cellular level of Chs are beneficial for cartilage tissue engineering 
[63]. The addition of Chs to the scaffold facilitates chondrogenesis of MSCs by providing 
a microenvironment that is favourable for the cellular growth and thus facilitates ECM 
formation [23].  
Keeping the above beneficial effect of Chs, the present dissertation work has been 
focused on examining the effect of Chs on SF/CS scaffold properties in order to enhance 
cell proliferation and GAG secretion properties of SF/CS scaffolds. The results and 
discussion of this experimental work are described in this chapter. 
5.3 Results and discussion 
5.3.1 Scanning electron microscopy (SEM) 
The morphology of the freeze dried SF/CS/Chs scaffolds prepared with different 
concentration of Chs is shown in figure 5.21. Table 5.5 shows the pore size range and 
average pore size of the SF/CS/Chs scaffolds. The pore morphology was observed to change 
from circular to oval shape when the concentration of Chs increases from 0.6 to 0.8wt%. 
On close observation, it has been found that all the scaffolds possess open pore structure 
with distinct pore walls and pore interconnectivity. The pore walls are more visible in 
scaffolds having Chs in the range between 0.8 - 1.2% (w/v). From the table it is observed 
that, a small change in pore diameter (109-103µm) was observed with increase in Chs (0.2-
1.2 %w/v). This decrease in pore size is due to the hydrophilic behavior of Chs, combined 
with the CS present in the scaffold. Similarly, Naeimi et al reported a decrease in pore size 
of the SF porous scaffolds from 121.45 ± 3.00–60 ±5.00.after the addition of Chs. Liang et 
al also studied the variation in pore size of collagen scaffolds when loaded with Chs [23]. 
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Figure 5.21: SEM images of SF/CS/Chs scaffolds with (a) (0.2), (b) (0.4), (c) (0.6), (d) (0.8), (e) (1) 
and (f) (1.2) % (w/v) of Chs respectively. All scaffolds possessed open porous network with highly 
interconnected pore structures. 
 
5.3.2 Porosity 
The measured porosity of the Chs added SF/CS scaffolds is tabulated in table 5.5.  A 
minimal increase in porosity (85-87%) was evident with increase in Chs content from 0.2- 
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0.8% (w/v). A similar trend of increase in porosity with the addition of Chs to collagen 
scaffolds was reported earlier by Liang et al [117]. But further increase in porosity was not 
observed with further increase in Chs content (beyond 0.8%). Thus the obtained porosity 
with Chs added scaffolds is higher than the porosity of SF/CS scaffolds representing the 
superiority of the SF/CS/Chs scaffolds in terms of providing better cellular environment to 
the scaffold. 
 
Table 5.5: Pore size, average pore size, and porosity of SF/CS/Chs scaffolds 
Sample Pore size (µm) Average pore size (µm) Porosity (%) 
Chs 0.2 (w/v) 61-212 109±26.5 85±3.21 
Chs 0.4 (w/v) 51-206 107±25.3 85.6±2.64 
Chs 0.6 (w/v) 48-201 106±32.2 86.0±1.98 
Chs 0.8 (w/v) 44-196 105±19.5 87±2.13 
Chs 1 (w/v) 41-191 104±22.6 87.9±2.16 
Chs 1.2 (w/v) 37-186 103±27.8 88.2±2.12 
 
5.3.3 Structural analysis 
FT-IR spectroscopy 
Figure 5.22 represents the FT-IR spectra of the SF/CS/Chs scaffold. The absorption band at 
1080cm−1 suggest the interaction between NH groups of SF and C=O and NH2 groups of 
CS in the scaffold. The interaction between SF/CS and Chs, as represented at 1260 cm−1, 
corresponds to the S-O stretching between SF/CS and Chs [63]. Thus, FT-IR analysis 
indicates that Chs interacts at molecular level with SF/CS blend. 
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Figure 5.22: FT-IR spectra of (a) SF/CS (80: 20), (b) Chs powder and (c) SF/CS/Chs scaffolds. The 
additional band in SF/CS/Chs scaffold is due to the interaction of Chs with SF/CS blend. 
 
5.3.4 Swelling behavior and water contact angle 
A comparative study of the % swelling observed with SF/CS (80:20) and SF/CS/Chs 
scaffolds during 42 hrs of SBF treatment is shown in figure 5.23. All the scaffolds show 
higher % swelling (255%) than SF/CS scaffolds (219%) which may be attributed partly 
because of the increased porosity of SF/CS/Chs scaffold and partly hydrophilic nature of 
Chs [126]. There is an initial increase in swelling % of the scaffolds between 2-8 hrs which 
is due to the flow of SBF into the pores of the scaffold. As indicated, both SF/CS and 
SF/CS/Chs scaffolds attained state of swelling equilibrium after 10 hrs of study, which is 
due to the saturation of SBF into the porous scaffold matrix. The trend of swelling is 
SF/CS/Chs > SF/CS/Glu > SF/CS.  
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Table 5.6 shows the variation of contact angle of water on SF/CS/Chs scaffold with 
variation of Chs content in the scaffold. The contact angle of the SF/CS scaffold was 
improved after the addition of Chs to the scaffold as represented in table 5.6. The water 
contact angle of SF/CS (80:20) scaffolds is 54.2±0.3°. SF/CS/Chs (0.2 -1.2 w/v) showed a 
contact angle in the range 50.1-46.8°. With gradual increase in Chs content, the contact 
angle was found to be decreased which may be attributed to the fact that the hydrophilicity 
of Chs is enhancing the wettability of the SF/CS scaffold. A similar increase in swelling and 
water uptake of CS / hyaluronan composite sponges due to the addition of nano Chs was 
reported earlier by Anisha et al [63].  
 
Figure 5.23: Swelling behaviour of (a) SF/CS (80:20), (b) SF/CS/Glu with 1% (w/v) Glu and 
SF/CS/Chs with (c) 0.2, (d) 0.4, (e) 0.6, (f) 0.8, (g) 1 & (h) 1.2 % (w/v) of Chs respectively. The rate 
of swelling increased between 2-8 hrs and after that they attained state of swelling equilibrium after 
10 hrs of study. 
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Table 5.6: Contact angle of SF/CS/Chs scaffolds 
Sample Contact angle(degree) 
SF/CS (80:20) 54.2±0.3 
SF/CS/Chs 0.2 (w/v) 50.1±0.2 
SF/CS/Chs 0.4 (w/v) 49.3±0.3 
SF/CS/Chs 0.6(w/v) 48.7±0.1 
SF/CS/Chs 0.8 (w/v) 47.4±0.7 
SF/CS/Chs 1 (w/v) 47.1±0.8 
SF/CS/Chs 1.2 (w/v) 46.8±0.6 
 
 
5.3.5 In vitro degradation 
Figure 5.24 depicts the in-vitro degradation pattern of SF/CS/Chs scaffolds. SF/CS/Chs 
scaffolds degraded at a faster rate (70%) in comparison to SF/CS/Glu (71%) and SF/CS 
(87.9%) scaffold. Initially the scaffolds showed a faster degradation, which is due to the 
rapid loss of scaffold material upon initial hours of contact with the SBF solution. With 
increase in time, there is a steady decrease in scaffold mass representing that the closure of 
pores resulting in lesser degradation. Increase in degradation rate may be due to the increase 
in scaffold porosity with increase in Chs content. The trend of degradation is SF/CS/Chs > 
SF/CS/Glu > SF/CS. A similar trend of increased degradation was observed earlier with 
incorporation of nano Chs with CS sponges [63]. 
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Figure 5.24: Degradation pattern of (a) SF/CS (80:20), (b) SF/CS/Glu with 1 % (w/v) Glu and 
SF/CS/Chs with (c) 0.2, (d) 0.4, (e) 0.6, (f) 0.8, (g) 1 & (h) 1.2 % (w/v) of Chs respectively. All the 
scaffolds showed an initial faster degradation and the rate of drgadation increased with increase in 
Chs content. 
 
5.3.6 Compressive strength 
The compressive strength of the SF/CS/Chs scaffolds was measured as 201±10, 203±11, 
203±15, 204±13, 200±11 and 200±12 with Chs content of 0.2, 0.4, 0.6, 0.8, 1 and 1.2% 
(w/v) respectively. As in case of Glu loaded scaffold, no significant change in the 
compressive strength due to addition of Chs was found.   
5.3.7 In vitro cell culture 
Cell attachment and morphology 
Enhanced cell attachment and proliferation, in terms of increased cell spreading, were 
observed with all the SF/CS/Chs scaffolds compared to SF/CS (80:20) and a slightly lower 
than SF/CS/Glu 1% (w/v) scaffolds as shown in figure.5.25. This enhanced cell proliferation 
achieved is due to the addition of Chs which is hydrophilic in nature thereby promotes cell 
attachment [21]. Also, a homogenous population of cells is seen in the SF/CS/Chs scaffolds. 
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In comparison, SF/CS/Chs scaffolds show lesser cell density than Glu loaded SF/CS 
scaffolds representing the superior cell supportive property of the later. 
 
Figure 5.25: FE-SEM images showing the cell attachment & cell spreading over the scaffolds. (a) 
& (d) SF/CS (80:20), (b) & (e) SF/CS/Glu 1% (w/v), and (c) & (f) SF/CS/Chs 0.8 % (w/v) scaffolds. 
A homogenous population of cells were present in the SF/CS/Chs scaffolds. 
 
Cellular activity by MTT assay  
The MTT assay results shows an increased trend in metabolic activity in SF/CS scaffold 
containing Chs during the progress of the culture as shown in figure 5.26. The metabolic 
activity of the SF/CS/Chs scaffold was higher than SF/CS scaffold representing the 
enhanced biocompatibility of Chs containing scaffold. But when compared to the 
SF/CS/Glu scaffolds, SF/CS/Chs scaffolds show lesser metabolic activity, as observed 
earlier in the cell attachment study.  
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Figure 5.26: MTT assay of (a) SF/CS (80:20) blend scaffold, (b) SF/CS/Glu scaffold with 1% (w/v) 
Glu and SF/CS/Chs scaffold with (c) 0.8 % (w/v) of Chs. The metabolic activity of the SF/CS/Chs 
scaffold was higher than SF/CS scaffold but lower than SF/CS/Glu scaffolds. 
Cellular proliferation by DNA quantification 
The proliferation of hMSCs over the scaffold was measured quantitatively by DNA 
estimation. Figure 5.27 shows an increase in DNA content with time in all the developed 
scaffolds with a varying degree of DNA content. Among the scaffolds used under study, 
SF/CS/Chs scaffolds showed significantly higher DNA content (355 ng/ml) than the SF/CS 
(80:20) (299 ng/ml) and SF/CS/Glu (349 ng/ml) scaffolds representing enhanced 
proliferation rate of hMSCs on the scaffolds. The increase in proliferation rate achieved is 
attributed to the presence of Chs which influences hMSC proliferation and promotes cell 
polymer interactions [63].The enhanced corneal stromal cell proliferation rate with addition 
of Chs to CS was also reported earlier by Yaoa et al [119 ]. 
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Figure 5.27:DNA assay of (a) SF/CS (80:20) blend scaffold, (b) SF/CS/Glu scaffold with 1% (w/v) 
Glu and (c) SF/CS/Chs scaffold with 0.8%(w/v) of Chs. SF/CS/Chs scaffold showed higher DNA 
content than the other scaffolds. 
 
Cytoskeletal analysis by confocal microscopy  
Understanding the cytoskeletal arrangement in a cell-scaffold construct is important to 
determine cell infiltration in the scaffolds [96]. Figure 5.28 shows the uniform distribution 
of hMSCs on the SF/CS/Chs scaffolds as observed from confocal microscopic images. 
Besides surface, the cells were also seen inside the scaffold matrix representing the superior 
interaction between Chs loaded scaffold (Fig.5.27). Also, the SF/CS/Chs scaffold shows 
reduced number of cells than the Glu loaded SF/CS scaffolds. 
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Figure 5.28: Confocal microscope images of scaffolds. (a) & (d) SF/CS (80:20), (b) & (e) 
SF/CS/Glu1 % (w/v), and (c) & (f) SF/CS/Chs 0.8% (w/v) after 7 & 14 days of culture respectively. 
A uniform distribution of hMSCs on the SF/CS/Chs scaffolds was observed from confocal 
microscopic images. SF/CS/Chs scaffold showed reduced number of cells than the Glu loaded 
SF/CS scaffolds. 
 
GAG assay 
As described earlier, GAG assay is important to determine the initiation of hMSCs 
differentiation into chondrocytes that leads to ECM synthesis [111]. Figure 5.29 shows the 
GAG content in SF/CS/Chs scaffolds and SF/CS (80:20) scaffolds. A steady increase in 
GAG production is observed with all the scaffold groups. Scaffolds containing Glu and Chs 
showed higher GAG secretion than SF/CS scaffolds throughout the culture time. Initially, 
after 7 days of culture, the SF/CS/Glu scaffolds showed a slight increase in GAG content 
than the SF/CS and SF/CS/Chs scaffolds. But after 14 and 21 days of incubation, the 
SF/CS/Chs scaffolds showed higher GAG content than the other groups of scaffolds. 
SF/CS/Chs scaffolds showed higher GAG secretion of 23µg/mg after 21 days of culture 
than SF/CS (80:20) (18µg/mg) and SF/CS/Glu scaffolds (21 µg/mg). The higher secretion 
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of GAG by the SF/CS/Chs scaffolds is due to the fact that Chs promotes differentiation and 
enhanced matrix production. A similar study was reported earlier with PEG and Chs based 
hydrogels by Varghese at al [81] in which the GAG secretion was found to gradually 
increase from 0.116 ± 0.011 g/g to 0.168 ± 0.008 g/g with the concentration of Chs in the 
PEG hydrogels .  
 
Figure 5.29: GAG estimation of (a) SF/CS (80:20) blend scaffold, (b) SF/CS/Glu scaffold with 1% 
(w/v) Glu and (c) SF/CS/Chs scaffold with 0.8% (w/v) of Chs. GAG secretion was found to be 
maximum for the SF/CS/Chs scaffolds. 
  
 
 
 
 
 
 
 
 
 
 
 
 
5.D EFFECT OF ADDITION OF GLU AND CHS IN 
COMBINATION ON THE SCAFFOLD PROPERTY 
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In the previous chapters, the addition of Glu and Chs individually were found to be 
beneficial improving a set of desired properties of SF/CS blend scaffolds. Both glucosamine 
sulfate and chondroitin sulfate loaded SF/CS scaffolds has shown enhanced hydrophilicity, 
cell adhesion and cell proliferation, metabolic activity and more importantly GAG 
production. Messier et al has reported the utilization of Glu and Chs in combination for the 
regeneration of cartilage tissue using 1500/1200 mg of Glu and Chs respectively which 
reduced pain, improved the strength and movement of older people. The synergistic effects 
of both Glu and Chs towards cartilage regeneration was also reported [26]. The combination 
of Glu and Chs have alleviated pain, discomfort and improved the overall joint function in 
the patient groups [24,25].  
Therefore, attempts have been made in the present chapter to investigate the effect of 
combination of Glu/Chs on the properties of the developed SF/CS scaffolds.To this end, 
three different weight percentage of Chs namely 0.5, 1 and 1.5 were added to the most 
efficient SF/CS/Glu 1%(w/v) solution developed in the previous section to prepare 
SF/CS/Glu/Chs porous scaffolds by freeze drying method. The combined effect of Glu (1%) 
and Chs (0.5, 1 & 1.5%) on various properties of SF/CS scaffold was assessed by 
physicochemical, mechanical and biological properties. This chapter describes the results 
and discussion on the above experimental research work.   
5.4 Results and discussion 
5.4.1 Scanning electron microscopy (SEM) 
The open porous structure and high pore interconnectivity of the SF/CS/Glu/ Chs are 
depicted by SEM images, as shown in figure.5.30). The pore size range of 40-196 (avg. 
106±26.3), 44-204 (avg 107±19.8) and 47-208 (avg 108±31.2) µm with 0.5, 1.0, 1.5% (w/v) 
of Chs respectively was measured with the developed SF/CS/Glu/Chs hybrid scaffolds. The 
scaffolds show similar pore morphology with a little variation in their pore size with various 
compositions. Moreover, no significant change in pore size was observed between these 
scaffolds and the individual SF/CS/Glu and SF/CS/Chs scaffolds.  
Chapter 5 Results and Discussion  
80 
 
Figure 5.30: SEM images of SF/CS/Glu/Chs scaffold with (a) Chs (0.5) (b) Chs (1) (c) Chs (1.5) % 
(w/v). The scaffolds showed similar pore morphology with a little variation in their pore size with 
various compositions. 
5.4.2 Porosity 
The porosity of the developed SF/CS/Glu/Chs scaffolds was measured as 88.7±1.12, 
90.2±1.3 and 90.6±2.1 with Chs content of 0.5, 1 and 1.5 % (w/v) respectively. A slight 
increase in porosity was achieved with the addition of Chs in comparison to SF/CS, 
SF/CS/Glu and SF/CS/Chs as shown in table 5.7. This increase in porosity may be explained 
as the presence of more hydrophilic groups in the scaffold material has enhanced the overall 
porosity of the scaffolds. This increase in porosity is beneficial to provide better 
microenvironment for cell-material interaction thereby facilitates neo tissue generation. 
Thus, these scaffolds show superior property in providing a highly porous scaffold matrix 
for cell support.  
 
Table 5.7: Pore size, average pore size, and porosity of SF/CS/Glu/Chs scaffolds. 
Sample Pore size (µm) Average pore size (µm) Porosity (%) 
Glu/Chs 0.5 40-196 106±26.3 88.7±1.12 
Glu/Chs 1 44-204 107±19.8 90.2±1.3 
Glu/Chs 1.5 47-208 108±31.2 90.6±2.1 
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5.4.3 Structural analysis 
FT-IR spectroscopy 
Figure 5.31 shows the FT-IR analysis of the SF/CS/Glu/Chs scaffolds. The band observed 
at 1080 cm−1 represents interaction between the SF and CS present in the scaffold. Bands at 
1614 cm−1 indicate the interaction of Glu in the scaffolds. The band at 1260 cm−1 signifies 
the S-O stretching due to interaction between SF/CS blend and Chs. Thus FT-IR analysis 
confirms the intermolecular interaction between both Glu and Chs in the SF/CS scaffold. 
 
Figure 5.31: FT-IR spectra of (a) Pure SF/CS, (b) SF/CS/Glu (c) SF/CS/Chs (d) SF/CS/Glu/Chs 
scaffolds.The characteristic band of Glu & Chs was found in SF/CS/Glu/Chs representing the 
individual interaction of Glu & Chs with SF/CS blend. 
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5.4.4 Swelling behavior and water contact angle 
Figure 5.32 shows the comparative study on the % swelling behavior of the developed 
scaffolds during the 42 hrs of swelling study. As observed from the figure, all the scaffolds 
showed an initial increase in swelling during the first few hrs but a steady swelling behavior 
(equilibrium state) was achieved with time, in about 10 hrs. Scaffolds with combination of 
Glu and Chs exhibited more swelling (263 %) than the scaffolds with individual Glu (246 
%) and Chs content (243 %) and SF/CS (219 %). Also, the scaffolds with 0.5 % (w/v) 
showed least swelling among the SF/CS/Glu/Chs scaffolds (258 %) followed by 1 % (w/v) 
(258 %) and 1.5 % (w/v) (262%) of Chs content. This increased swelling rate of the 
SF/CS/Glu/Chs scaffolds can be attributed to the combined hydrophilicity of Glu and Chs. 
The trend of swelling is SF/CS/Glu/Chs > SF/CS/Chs > SF/CS/Glu > SF/CS.  
The wettability of the SF/CS/Glu/Chs scaffolds was further confirmed by contact angle 
measurements. The hydrophilicity of the SF/CS/Glu scaffolds was slightly improved after 
the addition of Chs, as shown in table 5.8. SF/CS/Glu/chs (0.5-1.5 % w/v) showed a contact 
angle in the range 46.7-45.5 which is lower than the water contact angle measured with 
SF/CS/Glu 1% (w/v) scaffold is 49.5±0.8°. This represents the higher hydrophilicity, means 
higher wettability of the SF/CS/Glu/Chs scaffolds. Furthermore, decrease in contact angle 
with increase in Chs content was observed.  
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Figure 5.32: Swelling behaviour of (a) SF/CS (80:20) (b) SF/CS/Glu (1%) (c) SF/CS/Chs (0.8%) 
and SF/CS/Glu/Chs scaffolds with (d) 0.5 (e) 1 (f) 1.5 % (w/v) of Chs respectively. All the scaffolds 
showed an initial increase in swelling during the first few hrs but the swelling equilibrium was 
achieved after 10 hrs of SBF treatment. 
 
Table 5.8: Contact angle of SF/CS/Glu/Chs scaffolds 
Sample Contact angle(degree) 
SF/CS/Glu (1) 49.5±0.8 
SF/CS/Glu/Chs (0.5) 46.7±0.1 
SF/CS/Glu/Chs (1) 46.1±0.8 
SF/CS/Glu/Chs (1.5) 45.5±0.8 
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5.4.5 In vitro degradation 
The in-vitro degradation pattern of SF/CS/Glu/Chs scaffolds is depicted in figure 5.33. All 
the scaffolds degraded faster initially but reached a steady state of degradation after 7 days 
onwards. Glu and Chs in combination provided better scaffold degradation in comparison 
to the other scaffold groups. The SF/CS/Glu/Chs scaffolds showed faster degradation (57%) 
than the SF/CS/Chs (73%), the SF/CS/Glu (71%) and SF/CS (87.9%) scaffolds. However, 
scaffolds with Chs concentration of 1.5 % (w/v) showed the maximum degradation of 57%, 
followed by 61 and 67 % mass remaining with 1 and 0.5 % (w/v) respectively.Increase in 
degradation rate may be due to the increase in hydrophilic groups in the scaffold material 
with increase in Chs concentration. Overall, the trend of degradation is SF/CS/Glu/Chs > 
SF/CS/Chs > SF/CS/Glu > SF/CS.  
 
 
Figure 5.33: Degradation pattern of (a) SF/CS (80:20) (b) SF/CS/Glu (1%) (c) SF/CS/Chs (0.8%) 
and SF/CS/Glu/Chs scaffolds with (d) 0.5, (e) 1 & (f) 1.5 % (w/v) of Chs respectively. The 
degradation of SF/CS/Glu/Chs among the group with varied Chs content increased with increase in 
Chs content. 
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5.4.6 Compressive strength 
The compressive strength of the SF/CS/Glu/Chs scaffolds with 0.5, 1 and 1.5 % (w/v) Chs 
were determined as 200±12, 200±10 and 201±11 kPa respectively. Though the addition of 
Chs to SF/CS scaffold increased the compressive strength, the variation in strength between 
the varied Chs content in the study range is not statistically significant. More importantly, 
the addition of Chs and Glu in combination did not hamper the mechanical integrity of the 
scaffold. 
 
5.4.7 In vitro cell culture 
Cell attachment and morphology 
Scaffolds prepared with the combination of Glu and Chs showed a overall higher cell 
adhesion in comparison to the other scaffold groups namely SF/CS, SF/CS/Glu and 
SF/CS/Chs scaffolds as depicted from FESEM images in figure 5.34. This overall increase 
in cell adhesion is due to the synergistic effect of both Glu and Chs. The cells were found 
to attach well on the surface as well as inside the pores of the scaffolds.  
 
 
Figure 5.34: FE-SEM images of SF/CS/Glu/Chs scaffolds. (a) & (f) SF/CS(80:20), (b) & (g) 
SF/CS/Glu with 1% (w/v) of Glu, (c) & (h) SF/CS/Glu/Chs 0.5 % (w/v), (d) & (i)  SF/CS/Glu / Chs 
1 % (w/v), (e) & (j) SF/CS/Glu/Chs 1.5 % (w/v) scaffolds after 7 &14 days of culture. The cells are 
found to attach well on the surface and also inside the pores of the scaffold. 
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Cellular activity by MTT assay  
The cellular viability of the SF/CS/Glu/Chs scaffolds along with other scaffold groups was 
evaluated quantitatively by MTT assay as shown in figure 5.35. An increase in metabolic 
activity with culture period is evident with all the scaffolds with a varied degree of metabolic 
activity. However, SF/CS/Glu/Chs scaffolds showed better metabolic activity (2.3±0.05) 
than the SF/CS/Chs (1.73±0.03), SF/CS/Glu (2.15±0.03) and SF/CS (1.67±0.07) scaffolds. 
Between the various compositions prepared, SF/CS/Glu/Chs scaffolds with 0.5, 1 and 1.5 
% (w/v) Chs showed O.D. values of 2.3±0.05, 2.25±0.07 and 2.2±0.07 respectively. This 
increase in metabolic activity can be explained on the basis of the combined beneficial 
effects of Glu and Chs than their addition to SF/CS scaffolds individually. Both these 
components possess cell attachment motifs [24] which have enhanced the metabolic activity 
of the cells.  
 
 
Figure 5.35: MTT assay of (a) SF/CS (80:20), (b) SF/CS/Glu (1%) (c) SF/CS/Chs (0.8%) and 
SF/CS/Glu (1%) with (d) 0.5, (e) 1 and (f) 1.5% (w/v) of Chs scaffolds. An increase in metabolic 
activity with culture period is evident with all the scaffolds with a varied degree of metabolic 
activity. 
Chapter 5 Results and Discussion  
87 
 
Cellular proliferation by DNA quantification 
The cell proliferation was assessed by measuring the DNA content of the scaffolds. Figure 
5.36 shows an increase in DNA content with progress of culture in all the developed 
scaffolds with a varying degree of DNA content. Among the scaffolds, SF/CS/Glu/Chs 
scaffolds showed a higher DNA content of 380 ng/ml over a period of 21 days compared to 
SF/CS/Chs (355 ng/ml), SF/CS/Glu (349 ng/ml) and SF/CS (80:20) scaffolds (299 ng/ml) 
representing an enhanced proliferation rate of hMSCs particularly over SF/CS scaffold 
containing both Glu and Chs. The increase in proliferation rate is attributed to the presence 
of more cell recognition binding sites or specific peptides on the surface of scaffold matrices 
due to the presence of Glu and Chs in combination which has enhanced the cell - polymer 
interactions.  
 
 
Figure 5.36: DNA quantification of  (a) SF/CS(80:20) , (b) SF/CS/Glu (1%) , (c) SF/CS/Chs (0.8%), 
(d) Glu/Chs 0.5(%w/v) scaffolds. DNA content was found to increase in the SF/CS/Glu/Chs scaffold 
than the other developed scaffolds. 
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Cytoskeletal analysis by confocal microscopy 
The enhanced distribution of hMSCs on the SF/CS/Glu/Chs scaffolds is depictedfrom the 
confocal images as shown in figure 5.37. Cells were found to be well attached and spread 
throughout the scaffolds in comparison with the other scaffolds. Furthermore, a significant 
population of cells were found to penetrate inside the scaffold pores representing better cell-
material interaction than the SF/CS/Glu, SF/CS/Chs and SF/CS scaffolds.  
 
 
Figure 5.37: Confocal microscopy images (a) SF/CS (80:20), (b) SF/CS/Glu (1%), (c) SF/CS/Chs 
(0.8%), (d) Glu/Chs 0.5 (%w/v) scaffolds. after 7 days of culture. Significant cell population was 
observed in the SF/CS/Glu/Chs scaffolds. 
 
GAG assay 
GAG secretion was found to increase in all the scaffold groups with incubation time, as 
shown in figure 5.38. A significantly higher GAG secretion of 27µg/mg was achieved with 
SF/CS/Glu/Chs scaffold than the SF/CS (80:20) blend (18 µg/mg), SF/CS/Glu (21 µg/mg), 
SF/CS/Chs scaffolds (23 µg/mg) respectively.In the initial culture period of 7 days, the 
scaffolds with Glu and Chs in combination showed higher GAG secretion than the other 
scaffolds groups. With increase in culture time from 7 to 21 days, a gradual steady increase 
in GAG secretion was observed in the SF/CS/Glu/Chs scaffolds. The existence of Glu, 
which is a precursor for GAG synthesis [24] and Chs which is an important GAG 
component has enhanced the GAG secretion of the scaffolds[21]. Moreover, since Chs 
enhances differentiation and matrix production, the synergistic effect of Glu with Chs has 
enabled hMSCs seeded on the scaffold to produce more GAG [80].     
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Figure 5.38: GAG analysis on (a) SF/CS (80:20), (b) SF/CS/Glu 1%(w/v) , (c) SF/CS/Chs 
0.8%(w/v) and (d) SF/CS/Glu/Chs 0.5% (w/v) scaffolds. The presence of Glu & Chs in the SF/CS 
scaffold significantly increase the GAG secretion over culture period. 
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Damaged and/or diseased cartilage tissue due to injury and degeneration are of frequent 
phenomena in medical field. Current clinical methods of cartilage repair or replacements 
often fail to provide long lasting and complete recovery. As a consequence, the patient can’t 
restore normal cartilage function and thereby pain continues. In this context, tissue 
engineering offers a promising approach to repair and/or replacement of defect or disease 
providing restoration of normal cartilage function. 
In tissue engineering, the design and fabrication of 3D scaffold from a suitable 
biomaterial is one of the key challenges. Though in the last decade, a variety of biomaterials 
have been explored for the development of scaffold targeting cartilage tissue regeneration, 
but not a single biomaterial is able to satisfy all desired scaffold properties which opens up 
further research in this area. SF and CS are the attractive biopolymers though they have 
their own limitation which restricts their use in tissue engineering. However, recently, the 
combination of SF/CS biopolymers thereby resulted in SF/CS blend scaffold with superior 
properties has been reported. However, these studies were limited to the use of a specific 
ratio of SF/CS with the aim of exploring the suitability of the blend as scaffold material. 
Therefore, a systematic research effort is necessary to develop scaffold from SF/CS blend 
to make it potential for cartilage tissue regeneration. 
Keeping the above in view, the present research work aims to investigate the influence of 
different blend ratio of SF/CS on the scaffold properties to establish the most favourable 
blend ratio and further improvement of the properties of the SF/CS blend scaffold to 
facilitate cartilage tissue regeneration.The most interesting results obtained are described 
here.  
I. In the first phase of thesis work, different batches of 3D porous SF/CS scaffolds with 
varying blend ratios were prepared by freeze drying method. Among the scaffolds, 
SF/CS with 80:20 (v/v) was found to be the most favourable blend ratio. The scaffold 
possess open pore microstructures with interconnecting network of pores with desired 
pore size (71-201µm, porosity (82.2%) and compressive strength (190 kPa). The 
developed SF/CS scaffold was evaluated for its cell supportive property by in-vitro cell 
culture study using mesenchymal stem cells (MSCs) that were derived from umbilical 
cord blood. The scaffold was shown to provide suitable microenvironment for cell 
Chapter 6 Summary and Conclusion  
92 
attachment (SEM study) and cell proliferation (live dead assay) and metabolic activity 
(MTT assay). The differentiation ability of the scaffold towards cartilage specific ECM 
synthesis was indicated by the estimation of GAG by culturing hMSCs over the 
scaffold in chondrogenic media. Thus it has been established that the developed SF/CS 
(80:20) scaffold can be used as a potential artificial extracellular platform for cartilage 
tissue engineering applications. 
II. In this phase, the research was directed to improve the cell binding affinity and cartilage 
specific ECM formation ability of the SF/CS (80:20) scaffold by the incorporation of 
Glu as a precursor of GAG synthesis that resulted in SF/CS/Glu hybrid scaffold. 
Among the various compositions, SF/CS/Glu containing 1% of Glu was obtained as 
the most favourable composition that provided enhanced swelling (245%) and 
hydrophilicity (contact angle 49.5°) properties thereby exhibiting superior cell 
adhesion and cell proliferation. The scaffold was found to be superior to SF/CS scaffold 
in terms of cell supportive property. The addition of Glu further resulted in increased 
GAG synthesis (21 µg/ml), as observed during 21 days of culture in chondrogenic 
media indicating the enhanced chondrogenic specific ECM formation ability of 
scaffold. 
III. Chs is an important component of ECM. The addition of Chs to the scaffold favor cell 
adhesion, cell proliferation in chondrocyte cultures and ECM formation. Therefore, in 
this phase, efforts has been given to improve the above properties of the SF/CS scaffold 
by the addition of Chs. Among the various compositions, SF/CS with 0.8% Chs was 
the most favourable. The scaffold possess superior scaffold property than SF/CS 
scaffold. In comparison to SF/CS/Glu, SF/CS/Chs has shown a slightly higher cell 
proliferation and GAG secretion (23 µg/ml) ability. Therefore the scaffold is proven to 
promote cellular differentiation leading to ECM formation. 
IV. The synergistic effects of glucosamine sulfate and chondroitin sulfate towards cartilage 
regeneration has been reported by many reaserchers as they have been utilized for 
cartilage repair. Therefore, attempts have been made to investigate the effect of the 
addition of Glu and Chs by adding 0.5, 1 and 1.5% Chsin combination on the properties 
of SF/CS scaffold. To this end, SF/CS/Glu/Chs of different compositions were 
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prepared. Among these, SF/CS/Glu containing 0.5 % Chs was found to be best 
possessing superior hydrophilicity, cell adhesion, cell proliferation and cartilage 
specific ECM formation through GAG secretion (27 µg/ml) in comparison to other 
developed scaffolds. 
Overall, in this study a novel 3D porous SF/CS/ blend scaffold has been developed 
which can be used as a base polymeric scaffold for various cartilage tissue engineering 
applications. The cell affinity and GAG secretion property of the SF/CS scaffolds were 
further improved by the addition of Glu and Chs individually. Furthermore, cell 
proliferation and secretion of cartilage specific ECM has been enhanced by the addition of 
Glu and Chs in combination. Therefore, it has been demonstrated in this dissertation work 
that the developed SF/CS based porous scaffolds, SF/CS/Glu/Chs in particular can serve as 
a potential artificial extra cellular scaffold matrix for cartilage tissue regeneration in future.   
 
Suggested future work 
The future studies are essential in analyzing the various differentiation studies using the 
developed scaffolds and optimizing the various parameters. Also, cell scaffold construct 
studies using a bioreactor can enable to monitor the potentiality of the scaffold. In vivo 
studies using a suitable animal model is important to understand the in vivo biocompatibility 
of the scaffolds.  
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